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Zusammenfassung 
Im Rahmen der vorliegenden Arbeit zur Synthese von Radioliganden für den NMDA 
Rezeptor wurde die organische Synthese von vier Vorläufern mit Amidinstruktur zur 
Markierung mit Fluor-18 sowie die zugehörigen inaktiven Fluorverbindungen als 
chromatographische Standards entwickelt und durchgeführt. 
Die Synthese der Markierungsvorläufer folgte publizierten Reaktionswegen und 
gestaltete sich problemlos. Die für die Reaktion notwendigen Imidoester wurden in 
einer Pinner-Reaktion hergestellt. 2-Hydroxybenzylamin wurde aus dem 
korrespondierenden Nitril durch Reduktion unter Einsatz von Boran gewonnen. Seine 
Kopplung mit den Imidoestern geschah in DMF mit Hilfe von Triethylamin. Nach 
Kristallisation aus Methanol erhielt man die gewünschten Produkte in hoher Reinheit. 
Die cylische Verbindung wurde mittels Kopplung von 2-(Brommethyl)-benzonitril mit 
2-Hydroxybenzylamin gewonnen und aus Methanol umkristallisiert. 
Die Standardverbindungen wurden in einer Kopplungsreaktion von Imidoestern bzw. 
2-(Brommethyl)-benzonitril und ortho-Fluorethoxybenzylamin erhalten. Letzteres 
wurde in einer vierstufigen Reaktion aus Salicylaldehyd hergestellt. Aufreinigung der 
Substanzen erfolgte mittels Säulenchromatographie oder durch Umkristallisation aus 
Ethanol und Wasser. 
Die trägerarme Radiosynthese der gewünschten Fluorverbindungen wurde anhand 
der Modellverbindung N-(2-Fluorethoxybenzyl)-cinnamamidin getestet und optimiert. 
Die Reaktion mit 1-Brom-2-[18F]fluorethan in DMF oder DMSO unter Benutzung von 
Natriumhydroxid als Base ergab das gewünschte Produkt in guten bis sehr guten 
Ausbeuten (78 % nach 30 Minuten bei 80 °C in DMSO). Als Alternative von 
Dibromethan zur Herstellung von 1-Brom-2-[18F]fluorethan wurde auch Ethylenglykol-
1,2-di(p-toluolsulfonat) getestet. 
Das gewünschte [18F]fluoralkylierte Cinnamamidin konnte mittels HPLC und DC 
eindeutig identifiziert werden. Das Produkt kann nun in ausreichenden Mengen zur 
Anwendung für in vitro und in vivo Tests produziert werden. 
Erste Markierungsversuche am zyklischen Markierungsvorläufer verliefen nicht 
erfolgreich und erfordern weitere Untersuchungen. 
Abstract 
In the course of this work on the synthesis of radioligands for the NMDA receptor the 
authentic standards and labeling precursors of four compounds with an amidine 
structure was performed. 
Synthesis of the precursors followed reaction conditions given in the literature and 
was successful. The imidoesters used for the synthesis were obtained from their 
nitriles in a Pinner synthesis, while 2-hydroxybenzylamine was synthesized in a 
reduction of 2-hydroxybenzonitrile using borane as a reducing agent. After a coupling 
reaction of the amine and the imidoester in DMF using triethylamine as base the 
precursors were obtained in good yields and purified by crystallization from methanol. 
The cyclic standard compound was synthesized directly from 2-(bromo-
methyl)-benzonitrile and 2-hydroxybenzylamine in a ring closing reaction. Similar to 
the other precursors, crystallization from methanol produced a pure compound. 
The authentic standards were synthesized starting from salicylaldehyde. In a four 
step synthesis the desired ortho-fluoroethoxybenzylamine was obtained in good 
yield. Coupling of the amine with the respective imidoester or in the case of the cyclic 
compound 2-(bromomethyl)-benzonitrile gave the desired product which was then 
purified by column chromatography or by crystallization from ethanol and water. 
For the labeling procedure 1-bromo-2-[18F]fluoroethane was synthesized following a 
previously published pathway starting from 1,2-dibromoethane. An alternative route 
of radiosynthesis for this prosthetic group was tested using ethyleneglycole-
1,2-ditosylate. 
The labeling reaction was performed on one of the precursors testing both DMF and 
DMSO as solvents and using NaOH as base. Yields of N-(2-fluoroethoxybenzyl)-
cinnamamidine were about 78 % at 80 °C after 30 minutes in DMSO. 
The desired product can now be synthesized in sufficient yields for in vitro and in vivo 
evaluation studies. 
Labeling on the cyclic precursor was attempted utilizing DMSO as solvent, but no 
product could be found.
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1 Introduction 
1.1 Radionuclides in nuclear medicine 
In the year 1895 Wilhelm Conrad Röntgen discovered the hitherto unknown X-rays 
and in 1901 was awarded the Nobel Prize for this discovery. Only a year later, in 
1896, Henri Becquerel found that certain uranium-containing ores are able to blacken 
photographic plates. This was the first evidence for emission of energetic radiation 
from natural material and thus of radioactive decay. 
At the same time Marie Curie was looking for a possible topic for her thesis and 
decided to focus on uranium and the then called “Becquerel rays”. The first work the 
Curies did was to develop a method for measuring and quantifying the newly 
discovered radiation. Using an electrometer they were able to measure the electric 
charges occuring with each radioactive decay. Marie Curie studied several uranium 
containing samples and discovered that pitchblende was four-fold more radioactive 
than uranium, which led to the correct deduction that it must contain at least one 
other radioactive substance. 
The Curies isolated this radioactive material and thus discovered the element radium. 
They were able to extract 0.1 mg of radium chloride from several tons of pitchblende, 
and could determine the atomic weight of radium for the first time. Along with 
Becquerel, Pierre and Marie Curie received the Nobel Prize for Physics in 1903. 
After the untimely death of her husband, Marie Curie continued their work, 
discovered other new elements, e.g. polonium, and eventually was also awarded the 
Nobel Prize for Chemistry in 1911 "in recognition of her services to the advancement 
of chemistry by the discovery of the elements radium and polonium, by the isolation 
of radium and the study of the nature and compounds of this remarkable element". [1] 
The first practical application for radioactivity was established with the development 
of the radiotracer method by Friedrich Adolf Paneth and George de Hevesy in 1913. 
After first application of this principle to inorganic chemistry studies, De Hevesy 
extended the use to study metabolic processes in animals and humans. [2] De 
Hevesy’s work on the utilization of isotopic tracers and the recognition of the principle 
of the isotopes’ identical chemical and physiological properties led to the Nobel Prize 
for Chemistry 1943. 
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Invention and development of the cyclotron by Ernest Lawrence in 1930 established 
new methods for the production of artificial neutron-deficient radionuclides. For this 
discovery Lawrence was awarded the Nobel Prize for Physics in 1939. 
In 1938 the German scientists Otto Hahn and Fritz Straßmann discovered the 
formation of “fission” products upon neutron irradiation of heavy elements. Later in 
the same year Lise Meitner provided a valid physical explanation of the fission 
process, which finally led to development and construction of the first nuclear reactor 
in 1942 by Enrico Fermi and Leo Szilard. Now a way to production of many neutron 
rich radionuclides was open. For his discoveries Otto Hahn was awarded the Nobel 
Prize for Chemistry in 1944. [3] 
Today about 1600 artificial radionuclides are known. Due to constrictions to certain 
half-lives, type of radiation, energies of decay and a high (radio-) chemical purity, 
only a small portion of them are applicable in specific areas of life sciences. Positron 
(β+) emitters and γ-radiating nuclides are specially utilized as tracers for in vivo 
diagnostics. Specific nuclides that show γ-decay with energies of 100 to 600 keV are 
used and allow detection of γ-radiation outside the body, while ensuring that the dose 
the patient receives is as small as possible. The corpuscular α- and β−-emitters are 
exclusively utilized for therapeutical purposes. Because of their high linear energy 
transfer, they cannot be detected outside the body, if no accompanying γ-radiation is 
present. [4,5] 
Radioactive labeled biomolecules are important tools for the uncovering of 
physiological processes on the molecular level and enable monitoring of metabolism 
and not only the monitoring of morphological structures like computed (x-ray) 
tomography (CT) and magnetic resonance tomography (MRT or MRI) do. Positron 
emission tomography (PET) offers the possibility to quantify radioactivity and thus 
compute the amount of substance transported to different areas of the body. 
While the spatial resolution of PET is lower then that of classic structural imaging 
techniques like MRI, the capability to use PET as a method of functional imaging 
makes it a useful tool in diagnosing diseases. Utilizing bio-mathematical models 
together with computer based analyses of time-dependent distribution of radioactivity 
it is possible to determine a large amount of metabolic parameters. Benefit of PET is 
that besides calculating parameters like enzyme concentration, receptor density or 
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positron emission: 
electron caputure: 
rate of perfusion it is also possible to identify pharmacokinetics or 
pharmacodynamics. 
In a case with no-carrier-added substances the radioactive tracer needs to be applied 
only in very small (pico- to nanomolar) quantities. Because of this, utilization in vivo is 
possible in an optimal scenario without influencing physiological processes. 
There is a distinction between isotopic and analogous radiotracers, depending on 
whether the molecule is labeled using an isotopic or an analogous nuclide, which 
shows similar chemical properties. Especially with analogously labeled tracers, 
studies of their metabolism are mandatory When dealing with analogously-labeled 
tracers, the study of their metabolism is mandatory, since the chemically identical 
behavior of the labeled molecule has to be proven and fate of the radionuclide must 
be determined. [6] 
1.2 Basic principles of positron emission tomography 
Once it was established that the production of positron-emitting nuclides via 
cyclotrons was possible, using carbon-11, nitrogen-13 or oxygen-15 for analysis of 
biological and biochemical processes was a natural conclusion. During the 1930s 
they were employed for this purpose already; however, technical methods had not 
evolved far enough yet, and so further experiments could not be performed until 
computers, along with better detectors, were developed. When the development of 
detectors had advanced far enough that these radionuclides could be detected 
outside of the body, the use of positron emitters was introduced into biological and 
medical sciences. Modern day application of positron emitters is mainly PET, which 
makes use of the subsequent γ-radiation that occurs during decay of β+-particles. 
e
e
nep
np
ν
νβ
+→+
++→
−+
++
 
Equation 1.1: Decay channels of proton rich nuclides 
During β+-decay a proton in the atomic nucleus is transformed into a positron, a 
neutrino and a neutron. Proton-rich nuclides show this kind of decay only, if the 
decay energy is above 1022 keV, since the energy equivalent of two electron masses 
is needed for the conversion. If the decay energy is lower, proton-rich nuclides decay 
via electron capture (EC), during which an electron from an inner atomic-shell reacts 
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with a proton of the atomic nucleus producing a neutron and a neutrino (cf. Equation 
1.1). [7] 
An emitted positron must lose its kinetic energy before annihilation with an electron 
from the surrounding material is possible. During this process a positronium is formed 
which is similar to a hydrogen atom. Like hydrogen a positronium can exist in either a 
singlet (t½ = 1.25 · 10
-10s), or a triplet state (t½ = 1.4 · 10
-7s). When annihilation finally 
occurs, either two (from the singlet) or three (from the triplet) γ-quanta are emitted. In 
the case of two quanta both carry energy of 511 keV and are being emitted in almost 
180 degrees to each other. Since in condensed matter the pick-up process enables 
rapid transition to the singlet state, the triplet state can be neglected for the appliance 
with PET. [8] 
 
Figure 1.1: Scheme of a positron emission tomography: measurement of the 
radiation and computing of its position by coincidence measurement 
followed by computer based image reconstruction [9] 
For detection purposes a circular detector array is applied. The detector material is 
generally either bismuthgermanat (BGO) or lutetiumsilica (LSO). The emitted quanta 
are detected by coincidence counting, which filters out all events that do not occur 
within 5 ns (coincidence window) at exactly opposite detectors. 
Because of the emission of two γ-quanta in an angle of nearly 180 degrees and the 
detection with two diametric detectors, the counting efficiency is independent from 
the location of the decay between detectors. Absorption losses and scattering losses 
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can be calculated and corrected by utilizing a second measurement using an external 
radiation, thus enabling quantification of radioactivity. 
Modern equipment offers resolutions down to 3-5 mm in routine diagnostic devices 
but reaches down to 1 mm in dedicated animal systems. Also a three dimensional 
acquisition of radioactivity distribution is possible. Even administering doses in the 
pico- and nanomolar range is possible due to the high sensitivity of equipment. [10, 11] 
1.3 Radionuclides for labeling 
Table 1.1: Important PET nuclides and their nuclear data [from 6, 12] 
Nuclide Half-life Decay mode (%) Eβ+,max [keV] 
isotopic    
11C 20.4 min β+ (99.8) EC (0.2) 960 
13N 9.96 min β+ (100) 1190 
15O 2.03 min β+ (99.9) EC (0.1) 1720 
30P 2.5 min β+ (99.8) EC (0.2) 3250 
    
analogue    
18F 109.6 min β+ (97) EC (3) 635 
75Br 98 min β+ (75.5) EC (24.5) 1740 
76Br 16.1 h β+ (57) EC (43) 3900 
73Se 7.1 h β+ (65) EC (35) 1320 
120I 1.35 h β+ (64) EC (36) 4100 
124I 4.18 d β+ (25) EC (75) 2140 
    
metallic    
64Cu 12.7 h β+ (18) β- (37) EC (45) 655 
68Ga 68.3 min β+ (90) EC (10) 1900 
82Rb 1.3 min β+ (96) EC (4) 3350 
86Y 14.7 h β+ (34) EC (66) 1300 
94mTc 52 min β+ (72) EC (28) 2470 
 
Nuclides with a median to short half-life are mostly applied for PET, since the amount 
of radiation applied to the patient should be kept to a minimum and the fast 
measurement with PET does not make the usage of longer lived nuclides necessary 
for better imaging. 
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Often used nuclides are the so called isotopic radionuclides (cf. Table 1.1). Labeling 
with these give an authentic tracer whose pharmacological properties are unchanged 
in comparison with the unlabeled molecule. Due to short half-life of most of these 
nuclides, they can only be applied, if the labeling synthesis is performed at high 
speed and a quick distribution in the body is given. From the authentic nuclides only 
carbon-11 shows properties that allow extended syntheses and examination times, 
but still oxygen-15 and nitrogen-13 are sometimes used for special purposes. [6] 
Analogue tracers are labeled with a non-isotopic radionuclide, thus offering longer 
half lives. Nuclides whose electronic and steric properties will not change the 
characteristics of the molecule labeled with them are usually chosen. Most often 
nuclides are utilized, which offer longer half-life, thus enabling multi step syntheses 
and extended measurements. For example selenium-73 can be used as a structure 
analog for sulfur, due to its similar characteristics. An example is the labeling of 
methionine with selenium-73. [13, 14] Also iodine or bromine isotopes can often be 
used as analogues of a methyl group due to their similar spatial size. [15] 
Metallic nuclides like copper-64 or gallium-68 have not been applied as tracers as 
much as the isotopic or analogue tracers have in the past. For example copper was 
mostly used as free ion ([64Cu]Cu2+) for the diagnosis of Wilson’s Disease. Its 
possible use as a coordinated atom in an organic tracer molecule has been 
employed and explored more often in the last years. Research on this area of PET 
imaging is ongoing but has already led to new tracers offering new applications. [16] 
Table 1.2: Physico-chemical data of hydrogen in comparison to fluorine [from 6, 17] 
Physico-chemical properties Hydrogen Fluorine 
Mass 1 19 
Van-der-Waals-Radius [pm] 120 135 
Electronegativity 2.2 4.1 
C-X bond energy [kJ/mol]   
 aliphatic 398 444 
 aromatic 460 523 
Lipophilicity (∆logP)   
 aliphatic 0.19 -0.51 
 aromatic 0.19 0.43 
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The most important analogue radionuclide today is fluorine-18 (t½ = 109.6 min), 
whose isosteric and isoelectric properties often allow for the substitution of hydrogen 
atoms without altering the physico-chemical properties of a molecule too much. 
However its different C-X bond energy and higher electronegativity (cf. Table 1.2) 
change the dipole moment of the molecule, thus necessitating tests of the changed 
chemical and physiological behavior of a tracer upon labeling with it necessary. 
Thermodynamic stability of the carbon-fluorine bond is higher, so it can happen, that 
the bond cannot be broken within the metabolic processes and the molecule is more 
stable. On the other hand, fluorine is a good nucleofuge and the C-F bond may be 
less stable than the C-H bond of the corresponding authentic molecule, which 
underlines the importance of metabolic studies of the radiotracer or radioligand. 
The changed chemical characteristics of an analog molecule (or an analog tracer) 
are what made e.g. 2-[18F]fluor-2-deoxy-D-glucose ([18F]FDG) such a successful 
tracer. Metabolization is stopped after phosphorylation (“metabolic trapping”) making 
further chemical reactions impossible and inhibiting removal from the labeled site, 
thus allowing application of a simple three compartement kinetic model. [18, 19] 
Other advantages of fluorine-18 are the half-life of 109.6 min and the moderate β+-
energy, which helps to minimize radiation exposure and offers a good spatial 
resolution. The satellite concept allows distribution of fluorine-18 labeled components 
to smaller hospitals or universities that do not have a cyclotron on site, by producing 
fluorine-18 at a central production facility and delivering either the “raw” [18F]fluoride 
or the final tracer, for example [18F]FDG, to the site of usage. 
1.4 Production of fluorine-18 
Like other positron emitters fluorine-18 is produced at cyclotrons, but production at a 
reactor is also possible, though less favorable. Table 1.3 lists the most common 
methods of production. 
A detailed knowledge of the excitation functions of nuclear reactions to fluorine-18 
and potential byproducts is necessary to enable a clean production with high yields. 
Generally the target material is determined by the main product form needed. For 
routine production of [18F]fluoride the [18O]H2O-target has proven useful. Besides 
giving high yields, the enriched water can be separated from the produced 
[18F]fluoride using a ion exchanger resin or electrochemical anodic absorption and be 
reused after a purification process. [20, 21]  
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Table 1.3: The most important production pathways for fluorine-18 [from 22, 23] 
Reaction 18O(p,n)18F 16O(3He,p)18F 20Ne(d,α)18F 18O(p,n)18Fc) 
Target [18O]H2O
a) H2O Ne (0,1-0.2%F2)
b) 18O2, Kr (1%F2) 
Particle energy [MeV] 16 →  3 36 →  0 14 →  0 16 →  3 
Produced form of 18F 18F-aq 
18F-aq [
18F]F2 [
18F]F2 
Yield [GBq/µAh] 2.96 2.59 1.11 ~1.85 
Molar activity [MBq/µmol] ~600 · 104 ~50 · 103 ~100 ~ 600 
a)Ti-Target with Ti-window b)passivated Ni-Target  c)two step process 
An important factor in the favor of fluorine-18 is, that production is possible at smaller 
cyclotrons with a maximum proton energy of 17 or 11 MeV, which enables clinics to 
produce fluorine-18 as needed on site. 
Production of electrophilic [18F]F2 is accomplished using [
20Ne]neon or [18O]oxygen, 
but to obtain the product from the irradiated target, stable fluorine gas has to be 
utilized as carrier, which reduces specific activity greatly. [23] 
A further seldom applied method of production is reactor based. Irradiation of a 
lithium-6 enriched target (LiOH or LiCO3) with neutrons leads to a 
6Li(n,α)3H reaction. 
The produced tritons have an energy that is high enough to allow a consecutive 
nuclear reaction with oxygen-16 atoms present in the target material: 16O (t,n) 18F. 
Because the average cross section for the production of fluorine-18 over the effective 
range is only 87 mbarn the yield is not very high. The considerable amounts of tritium 
produced during the irradiation and the low specific activity obtained make this 
production pathway unprofitable and it is therefore not used often, but it offers a way 
of producing fluorine-18 when no cyclotron is available. [24] 
1.5 Specific problems of reactions under no-carrier-added 
conditions 
Radiopharmaceutical products are usually used in subnanomolar quantities, which 
make an induction of toxic or immunologic reactions almost impossible. The tracer is 
utilized in quantities that will not reach a saturation concentration, therefore it is very 
important to obtain the labeled products in high specific activities. This is only 
possible if the product is kept free of stable isotopes, which would dilute the specific 
activity of the radioactive product. 
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The possible states are differentiated as follows: 
- carrier-free, c.f. 
- no-carrier-added, n.c.a. 
- carrier-added, c.a. 
A carrier free substance can theoretically only be produced if no natural stable 
isotope of the used nuclide exists. Astatine is an example of radionuclides that lead 
to carrier free products. Syntheses utilizing nuclides for which at least one stable 
isotope exists lead to no-carrier-added products, since a dilution with the stable 
isotopes is practically inevitable. These are carried into the reaction from solvents, 
atmosphere, chemicals and for example target and reaction vessels. 
Certain reactions are only possible if carrier is added to the synthesis. The best 
known example are syntheses utilizing [18F]F2 that has to be produced using 
elemental carrier. Due to their low specific activity carrier added radiochemicals are 
not suitable for studies unless the corresponding natural compound is already 
present in the body in high concentrations and thus a higher amount of the stable 
product can be tolerated. 
Specific activity AS is defined as activity A per weight (m in gram). 
[7] 






=
g
Bq
m
A
AS
      
Equation 1.2 
While activity A is defined as 
[ ]Bq
T
2lnN
N
dt
dN
A
2
1
⋅
=⋅== λ
    
Equation 1.3 
The combination of equation 1.2 and equation 1.3 necessarily leads to the conclusion 
that specific activity will decrease, if half-life (T1/2) or mass become larger. 
Fluorine-18 has a theoretical maximum molecular activity of 6.3.1010 GBq/mol that 
can be calculated by adding the Avogadro constant into equation 1.3. 




⋅
⋅
=⋅=
mols
1
T
ln2N
NA
2
1
A
Amax,S λ
 



⋅=



⋅
⋅⋅
=⇒
mol
Bq
106,3378
mols
1
6586,2
ln2106,0221
A 19
23
maxS,
       
Equation 1.4
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This value of activity cannot be reached under practical conditions, since stable 
fluorine-19 cannot be excluded from the reaction. Thus the total number of atoms 
(NA) is always larger than the number of radioactive atoms (N), which leads to AS 
being smaller than AS,max. 
Nevertheless high specific activities can be reached for many radiolabeled 
compounds but require working with quantities within the subnanomolar range. When 
working with such small amounts, effects that do not influence reactions on 
macroscopic scales can be important factors that merit consideration. For example 
adsorption on walls of the reaction vessel or side reactions with even the smallest 
impurities in the chemicals can occur, since even miniscule impurities present within 
the labeling precursor will exceed the amount of the radionuclide. 
In labeling reactions unexpected side reactions are often witnessed that normally 
would not occur or only occur in smaller percentages. This is due to the use of some 
of the reaction partners in a 106-fold excess. The concentration of non-radioactive 
reaction partners stays nearly constant through the reaction when compared to the 
radioactive compound, which is why the labeling reaction can be considered to be of 
pseudo-first order. Also due to the low amount of radioactive material it is statistically 
almost impossible that an already labeled molecule will undergo a second reaction 
with the radioactive nuclide. 
Maximum yield is connected to the decay of the nuclide and therefore to its half-life, it 
will be lower the longer the duration of complete synthesis, since a higher amount of 
the product will have decayed. To gain good yields, it is important to let the labeling 
reaction take place as late as possible within a multi-step synthesis, as decay of the 
labeled product will be minimized that way. Additionally a fast labeling procedure 
and, if necessary after the labeling step, fast organic syntheses need to be 
employed, since it is of high importance to reduce overall reaction time. 
For most radiochemical reactions reaction yields are given as radiochemical yield, 
which is decay corrected and not connected to the duration of the synthesis 
anymore. 
Important criteria for a no carrier added synthesis are: 
- use of proper material (chemicals, solvents and reaction vessels) 
- short duration of synthesis 
- labeling reaction utilized as late as possible within a multi-step synthesis 
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1.6 Labeling methods with fluorine-18 
The most often used methods of synthesis for a fluorine-18 labeled molecule are  
- direct labeling via electrophilic substitution 
- direct labeling via nucleophilic substitution  
- indirect labeling via synthons 
1.6.1 Electrophilic substitution 
Electrophilic substitution offers access to fluorine-18 labeled arenes and alkenes. 
Elemental fluorine ([18F]F2) is utilized most often but also the less reactive reagents 
acetylhypofluoride ([18F]CH3COOF) or xenondifluoride ([
18F]XeF2) are applied, if 
milder reaction conditions are necessary. Because of its corrosiveness and extreme 
reactivity under normal conditions, fluorine needs to be handled carefully, which 
makes radiosyntheses with [18F]F2 very demanding. 
[18F]F2 can only be produced in good yields in carrier-added form (cf. above). Highest 
specific activities reached are at about 55 GBq/µmol, this is still 100-fold less than 
product yields of the no-carrier-added [18F]F-. [25, 26] 
When using carrier-added [18F]F2, where each labeled molecule (which is only about 
every 1015 th molecule) will carry only one fluorine-18 atom, the radiochemical yield is 
limited to 50%. 
58% 15% 6%
[18F]F2
 
Scheme 1.1: Yields of the electrophilic substitution of fluorobenzene [from 27] 
As shown in Scheme 1.1 the high reactivity of [18F]F2 leads to mixture of products 
that further reduce the yield. The use of organometallic labeling precursors offers an 
alternative, by introducing a leaving group into the precursor and will give a lower 
amount of unwanted side reactions (cf. Scheme 1.2). [28] 
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[18F]CH2CO2F
[18F]F2 or
 
R = OCH3, CH3, H, F, Br, CF3, NO2 
M = Si, Ge, Sn 
Scheme 1.2: Electrophilic aromatic [18F]fluorodemetallation [from 28] 
For production of radiopharmaceuticals electrophilic fluorination can only be used if 
low specific activities can be tolerated, as with non toxic substances that can be used 
in high concentrations or if high concentrations of non-isotopic carrier are present 
within the body in any case. This is the case for [18F]FDG where D-Glucose functions 
as non-isotopic carrier. 
1.6.2 Nucleophilic fluorination 
For synthesis of substances with high specific activity, only [18F]Fluoride is practically 
useful, because a no-carrier-added synthesis is necessary. 
Post production the fluoride is obtained in an aqueous solution and is highly solvated. 
(∆Hydrate=506 kJ/mol) 
[29] In this state nucleophilic reactions are impossible which 
makes it necessary to remove the deactivating aqueous layer. This is generally done 
by azeotropic drying with acetonitrile. At the same time a soft cation is added to the 
fluoride, often Kryptofix 2.2.2®/K+, an aminopolyether with potassium as ion, is 
applied. Under these conditions the potassium is coordinated by the aminoether and 
yields a soft ion (according to the HSAB-Principle). To generate a proton free 
medium a base is added, preferably a non-nucleophilic anion like CO3
2-. If the 
precursor is labile to strong basic conditions, a K2CO3/K2C2O4-mixture or the use of 
tetraalkyl ammonium salts is often helpful. [30, 31, 32, 33] 
After drying of the [18F]fluoride the reaction precursor, dissolved in a suitable polar 
aprotic solvent is added. Often used solvents are acetonitrile (MeCN), dimethyl 
sulfoxide (DMSO) und N,N-dimethylformamide (DMF). Alternatives to these classic 
conditions may be offered by the utilization of ionic liquids or tertiary alcohols, which 
are still in development. [34, 35] 
While labeling under standard conditions with aprotic solvents, it is of utmost 
importance that no protic substances or metal cations are present, since both will 
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deactivate [18F]fluoride due to the formation of hydrogen bonds or metal complexes, 
due to the high charge density of the fluorine anion. 
Under the conditions given above, the reaction will be occurring under SN2 conditions 
in aliphatic systems. This means a Walden inversion will take place. The precursor 
needs to be synthesized accordingly, if a stereospecific product is desired. Leaving 
groups for both aliphatic and aromatic reactions generally are halogens or 
tosylates/triflates. [36] 
A general example is the synthesis of [18F]FDG (cf. page 6), that is synthesized from 
a tetra-acetylated mannose triflate precursor. The conversion of the triflate into the 
labeled compound under polar aprotic conditions leads to an inversion of 
configuration, which subsequently gives the desired D-glucose derivate. [37] 
During aliphatic reactions a β-elimination can happen, which will yield H18F as a side 
product. Due to the high excess of base under which the labeling is conducted, the 
hydrogen fluoride will be converted back into the free ion and be available for further 
reactions. 
For nucleophilic substitution reactions in the arene ring, an activating group is 
necessary, which needs to be positioned ortho or para to the labeling site. Electron 
withdrawing substituents are utilized whose –M and –I effects lower electron density 
at the target carbon atom. Often used activating groups are cyano and carbonyl 
groups. [38, 39] 
M18F
 
Y = NO2, CN, CHO, RCO, COOR, Cl, Br, I 
X = (R3)N
+
, NO2, Br, Cl, I 
M = [K⊂ 2.2.2]+, R4N+, Cs+, Rb+ 
Scheme 1.3: Nucleophilic aromatic substitution with n.c.a. [18F]fluoride [from 38] 
Leaving groups for reactions on the aromatic ring are often trialkylated ammonium 
groups as well as aryliodinium salts (cf. below), which are the best nucleofuges. The 
choice of the counterion of the trialkylated ammonium group has a high impact on the 
radiochemical yields. Triflate ions are often used, while perchlorate and iodide are 
employed less often. [40] Further often utilized leaving groups are the nitro-group and 
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halogens, though the latter should not be applied unless low specific activities can be 
tolerated. [39] 
If no strong activating substituents are present in the precursor molecule, utilization 
of the trimethylammonium group as leaving group will give significant amounts (about 
80%) of [18F]fluoromethane and thus lower the radiochemical yield of the 
[18F]fluoroarene. Only by using strong activating groups like the nitro or cyano group 
this reaction can be prevented and better yields of the [18F]fluoroarene are gained. 
X-
18F-
 
X
-
 = I, Br, Triflat, Tosylat 
R, R’ = H, CH3, C4H9, OCH3, Cl, Br, I 
Scheme 1.4: General principle of [18F]fluorination with diphenyliodonium salt [from 42] 
Non activated or only slightly activated molecules can be labeled employing the 
recently developed reaction with diphenyliodonium salts (cf. Scheme 1.4). Use of 
symmetric iodonium salts (R = R’) leads to a single radioactive product with high 
radiochemical yields. [41] Asymmetric compounds (R ≠ R’) will yield two different 
products, whose ratio will depend on the substituents present in the phenyl rings. 
Electron-withdrawing groups like halogens will favor the formation of the substituted 
[18F]fluoroarene, while electron-donating groups like the methoxy-group will lead to 
the sole formation of [18F]fluorobenzene (for R = OMe, R’ = H, cf. Scheme 1.4). 
Counter ions used with diaryliodonium salts are generally triflate, tosylate or iodine 
and bromine. [42] 
Another possibility to synthesize molecules that normally are not accessible through 
direct labeling is to insert an activating group into the arene ring, perform the labeling 
synthesis and then remove the activating group from the ring, giving the desired 
product. Examples are the simple removal of aldehyde groups using Wilkinson’s 
catalyst (chlorotris(triphenylphosphine)rhodium(I)) or the hydrohalogenation of 
halogens with tributyltin hydride or sodium borohydride. The above mentioned 
reactions allow the synthesis of [18F]fluoroarenes that normally would not be available 
due to the lack of an activating group in the ring. [43] 
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The often utilized Balz-Schiemann reaction is not useful in radiochemistry, since the 
counterion to the diazoniumion is tetrafluoroborate, which is used as donor of 
fluorine. Since only one of its fluorine atoms can be substituted with [18F]fluorine 
maximal radiochemical yield is 25% and low specific activities will result. The use of a 
tetrachloroborate anion as an alternative has been suggested. This gives products 
with better specific activities, even though yields are not much higher, since the 
reaction mechanism follows a SN1 pathway and side reactions with other 
nucleophiles present in the reaction mixture are common. [44] 
1.6.3 Radiolabeling using synthons 
If a direct labeling procedure is not possible under the conditions mentioned above, 
for example due to complex molecular structures, a labeling reaction using a 
pre-labeled synthon is a possible alternative. These mostly two step reactions consist 
of a first labeling reaction in which a smaller precursor molecule is labeled and then 
is coupled with a second precursor, giving the desired final product. 
 
R = –CH2OH, –CH2X, –OH, –H 
Scheme 1.5: Often utilized labeled synthons for further reaction [from 27] 
There are two major methods for an indirect labeling reaction. Either one or two 
additional steps are added after the primary labeling reaction. Often the labeled 
synthon is directly reacted with a second compound and the final radioactive product 
is obtained, or the labeled precursor is transferred into a reactive synthon which is 
then coupled with the second precursor in a built-up synthesis (cf. Scheme 1.5). 
To give good overall yields the reactions chosen for any indirect labeling with a 
labeled synthon must have a short reaction time with good to very good yields and a 
simple and fast way of obtaining the final product. 
Good results with fast reaction conditions are found when using alkylating, acylating 
or amidating agents. For 18F-fluoroalkylation a bifunctionalized alkane is labeled with 
[18F]fluoride and then coupled with an amino, hydroxyl or thiol group. [45,46 47] 
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18F- RYH
 
X = Tosylat, Triflat, Br, I Y = N, O, S R = Alkyl, Aryl 
Scheme 1.6: 18F-fluoroalkylation utilizing a functionalized alkane [45] 
This reaction allows the synthesis of a wide range of radiopharmaceuticals, for 
example it has been used in the synthesis of dopaminergic or serotonergic receptor 
ligands. [48] 
While the method introduced by Block et al. suggests [18F]fluoroethyltosylate as the 
preferred labeling agent rather than 1-bromo-2[18F]fluoroethane (BFE), recent 
publications reintroduced the latter as efficient labeling agent. [45, 49] While a 
distillation was previously required to separate labeled [18F]BFE from its precursor, 
Comagic et al. introduced a chromatographic method utilizing solid phase exchange 
cartridges, which enables automation of the process. [49] 
The similar acylation reaction using a previously 18F-labeled ester can be performed 
in aqueous solutions, where the labeled agent is coupled with an H-acidic compound. 
Another possibility is the labeling of functionalized amines, which are subsequently 
coupled with esters to give the corresponding amide. Both reactions allow for the 
synthesis of labeled peptides or proteins, for example Biotin, Octreotide and 
insulin. [50, 51, 52] 
A newly employed method of labeling peptides is the so called click-chemistry, a term 
introduced by K. Barry Sharpless that refers to a method of synthesis which utilizes 
modular building blocks that react readily to the desired product. [53] Of high interest 
for the synthesis of labeled compounds is the 1,3-dipolar Huisgen cycloaddition. 
While the uncatalyzed reaction needs harsh reaction conditions and gives a mixture 
of the 1,4- and the 1,5-disubstituted triazole product, the copper catalyzed variant 
allows reactions at room temperature and at moderate pH, giving only the 1,4- 
disubstituted triazole. [54,55] 
This reaction has first been suggested for the synthesis of labeled peptides by two 
groups using different approaches. While Marik et al. used a labeled alkyn-synthon, 
Glaser et al. decided on the labeled azide, since alkynes are more readily available 
and thus easier to synthesize as the peptide-synthon. [56, 57] 
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K[2.2.2]18F
CuI, i-Pr2NEt, Na+ ascorbate
10 min, RT
Cu2+ ascorbate
15 min, RT
K[2.2.2]18F
 
Scheme 1.7: Radiosytheses utilizing click-chemistry as introduced by Marik et al. 
(upper scheme) and Glaser et al. (lower scheme) [56, 57] 
Aside from click chemistry other new methods have recently found their way into 
radiochemistry, the use of an enzyme (fluorinase) is under development and even 
though reactions times are still longer than desired (1-4 hours) the use of a 
bio-catalyst opens possibilities for labeling under mild conditions with high chemo-
selectivity. [58] For the labeling of peptides thiol labeling agents has been of great 
interest and a wide range of possible reagents is currently in development. Other 
possibilities include silicon, phosphor or boron carrying synthons which would offer 
easier preparation and hopefully the developement of labeling kits. [59, 60, 61] 
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1.7 Structure of the central nervous system (CNS) 
Signal transduction in the nervous system is conducted via electrical or chemical 
processes. Neurons, the cells which enable regulation of our being, register a 
stimulus and react to it with an increased potential in their membranes, transporting 
the signal electrically from the dendrites towards the axons, the ends of the nerve 
cells. 
To process the information reaching our brain in every single second of our life, 
millions of neurons are interacting with each other, transmitting and storing 
information. Both of these procedures do not only rely on signal transduction, but 
also on targeted potentiation or blocking of certain signals. 
 
Figure 1.2: Signal transduction in the CNS via the axon and transmission to the 
next neuron at the synapse [62] 
The junction between two nerve cells where an axon meets a dendrite is called a 
synapse. At the synapse the cells do not have direct contact, but rather are 
separated by the so called synaptic cleft. Signal transduction through the synaptic 
cleft proceeds by neurotransmitters, chemical compounds that are synthesized in the 
neuron and stored in vesicles in the axon terminal. If a stimulus arrives at the 
synaptic bouton, the vesicle merges with the cell membrane and sets the 
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neurotransmitter free (exocytosis). The neurotransmitter diffuses through the synaptic 
cleft towards the dendrite, where it binds to transmitter specific receptors and once 
again a membrane potential change occurs and the signal is further transported 
through the excited nerve cell. Generation of the potential can occur by different 
means. Either an ion channel opens, letting cations diffuse into the cell, generating a 
potential difference, or by secondary intracellular transmitter proteins. 
Depending on the receptor type, either an ion channel is opened or closed, or a 
change of confirmation of a membrane protein will lead to cascade of internal signal 
transduction, which then can also lead to the opening of ion channels. Calcium, 
sodium, potassium cations or chloride anions can diffuse through the ion channels 
into the cell and generate a potential change that will lead to the generation of a 
signal and its electric transport towards the next synapse. 
Unlike ion channel receptors, which regulate the influx or efflux of ions, so called 
G-protein coupled receptors work by generating a signal through the release of cyclic 
adenosine monophosphate (c-AMP) or cyclic guanosine monophosphate (c-GMP) as 
first signaling molecule of a complex cascade inside the receptive cell. 
Receptors also occur presynaptic on axons (so called autoreceptors), where they are 
important to the regulating system of the synapse. Aside from the compounds that 
normally act as neurotransmitters, other endogenous compounds (for example 
hormones) and artificial molecules such as synthesized receptor ligands (like many 
CNS active pharmaceuticals) influence receptor function. Both functions, as agonist 
or antagonist, are possible. So called agonists are substances which stimulate the 
receptor, while substances which block it are called antagonists. 
Every axon contains a neurotransmitter specific for this type of cell. For regulation 
after release into the synaptic cleft the neurotransmitter can be removed by reuptake 
or metabolic elimination which causes resynthesis in the releasing cell. Important 
neurotransmitters are acetylcholine, amino acids (for example γ-amino-butyric acid or 
glutamate, the salt of glutaminic acid), monoamines (serotonine, dopamine) and 
oligopeptides. 
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1.8 Ionotropic glutamate receptors 
The glutamate receptor is primarily expressed in the central nervous system. In the 
brain it is mainly situated on membranes in the cerebellum and hippocampus. It is the 
most important excitatory neurotransmitter in the mammalian brain. It probably plays 
an important role in learning and memory processes and is one of the receptors 
involved with neurodegenerative diseases. [63] 
 
Figure 1.3:  Overview of the different glutamate receptors [64] 
↑PLC indicates activation of phospholipase C 
↓AC indicates inhibition of adenylate cyclase 
Depending on the method of signal transduction glutamate receptors are divided into 
metabotropic and ionotropic receptors. The metabotropic glutamate receptors have 
an important role in regulation of the glutamatergic receptor system by acting as 
modulators of the ionotropic glutamate receptors. Ionotropic receptors are subdivided 
into NMDA, AMPA or Kainate receptors, after their respective agonists N-methyl-D-
aspartat (NMDA), α-amino-3-hydroxy-5-methylisoxazol-4-propionsäure (AMPA) and 
kainate. 
Composition of the receptor assembly in the cell wall differs from that of other known 
ionotropic receptor types such as the acetylcholine or GABA receptor. The ionotropic 
glutamate receptor consists of four subunits that combine into the working receptor. 
Each subunit contains four membrane domains (MD), only three of which truly pass 
through the membrane. The second MD forms an intracellular loop. In consequence 
this leads to each subunit displaying an intracellular carboxyl ending (cf. Figure 
1.4). [64] 
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Figure 1.4: Possible build of a glutamate receptor 
1.8.1 Kainate receptors 
Kainate receptors have two kinds of subtypes which are identified as GluR5 through 
GluR7 and KA-1 and KA-2. The actual receptor is build either solely from subtypes of 
the GluR5 to 7 kind, or is a combination of the former with KA-1 or KA-2 units. The 
latter cannot give functioning receptors in a homomeric arrangement. [64] 
 
Kainic acid LY339434 
Figure 1.5: Examples of selective agonists of the Kainate receptor 
Due to the lack of selective agonists the kainate receptor for a long time has not been 
as thoroughly examined as the AMPA and NMDA receptors. Only after the synthesis 
of selective agonists was successful, research in that area was brought forward. 
OH
O
NH
O H
O
H
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Figure 1.6: Structure of the GluR5 selective antagonist LY382884 [65] 
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Using agonists for the AMPA receptor as model compounds, a series of competitive 
and non competitive ligands was synthesized. Several antagonists were specially 
developed for the GluR5 subtype. Development of allosteric ligands is hoped to lead 
to further insight into the kainate receptors. 
1.8.2 AMPA receptors 
AMPA receptors are divided into subtypes named GluR1 to 4. The receptor consists 
of four subunits which are heteromerically arranged. All subunits can exist in different 
spliced versions. During gene transcription mRNA is edited, so that two alternate 
varieties of the protein will be generated. Generally these differ only in a few amino 
acids. With AMPA receptors RNA editing generally occurs between the 3rd and 4th 
transmembrane domain (between MD3 and MD4) and on the C-terminal end 
(cf. Figure 1.4). One important change made by this version of alternate splicing is 
the existence of the so called Flip and Flop versions of the subunit. Both are 
differently folded versions of the protein, which results from the change of several 
amino acids in the protein structure in the area between the third and forth 
membrane domain. 
While the Flip version is predominant in the prenatal brain, the Flop variant only 
develops postnatally and reaches equivalent levels in the adult brain. Both version 
show different properties in desensitization and behavior towards allosteric 
modulators, which leads to the assumption that interaction between these modulators 
and the receptor occur in the area that has been modified. [64, 66, 67] Pharmacologic 
and kinetic properties of both variants are so distinct that different receptor ligands 
exist for each of them. 
1.8.2.1 AMPA receptor agonists 
Most agonists developed for the AMPA receptor were similar in structure to the 
original agonist AMPA itself. Different agonists show different rates of 
desensitization. While glutamate and AMPA lead to a fast reaction of the receptor, 
weaker agonists do not lead to complete desensitization. 
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R-AMPA L-Quisqualic acid 
Figure 1.7: Examples of AMPA receptor agonists 
1.8.2.2 AMPA receptor antagonists 
Both competitive and non-competitive antagonists for the AMPA receptor are under 
development. Starting from quinoxaline derivatives like NBQX a wide range of 
potential competitive antagonists have been designed. Their poor solubility in water, 
however restricts their application so far. Non-competitive antagonists are also called 
negative allosteric modulators. They do not bind at the same binding site as the 
agonist and competitive antagonists. Design of competitive antagonists started from 
2,3-benzodiazepines, followed by phthalazines. [68] Their selectivity towards specific 
subunits is not very high and research for more selective antagonists is ongoing. 
 
a) NBQX    b) (R)-LY300164 
Figure 1.8: Examples of a) competitive and b) non-competitive AMPA-antagonists 
1.8.3 NMDA receptors 
Subunits of the NMDA receptor are called NR1, NR2A to D and NR3A and B (cf. 
Figure 1.3). A functioning receptor again consists of four units, two of which must be 
NR1 subunits. The other two may either be NR2 or NR3 units. [64] The agonist 
glutamate binds to the NR2 subunit, while the necessary co-agonist glycine has its 
binding site on the NR1 unit. [69] In order to activate the receptor, glycine has to 
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present when glutamate binds. It has been reasoned that in order to enable fast 
excitation, the glycine binding site is almost constantly occupied with glycine. [70] 
The NMDA channel is permeable by Na+ and K+ ions, but also by Ca2+, which other 
glutamatergic receptors are not permeable to. In state of rest the receptor is blocked 
with Mg2+, but the block is removed once depolarization of the receptor membrane 
occurs (meaning a change of the resting potential of the cell). [71] 
The NMDA receptor plays an important role in memory and learning, its wide 
distribution in the mammalian brain hints to its importance. While receptors that are 
prevalent prenatally contain NR2B units, in the postnatal brain receptors containing 
NR2A units increase and are the most prevalent in adult brains. At the same time 
receptors containing only NR2B units can be mainly found in the forebrain, 
accompanied by such containing one NR2A and one NR2B unit, the latter probably is 
the major receptor in the adult forebrain. [72] 
The fact that the distribution and composition of the receptor changes postnatally 
indicates that it has a role in learning and memory. The model currently used to 
explain how our brain stores information is called Long Term Potentiation (LTP) and 
consists of the principle that synapses which get activated more often form a stronger 
pathway and durably increase the effect of synaptic transmission. [73] Research 
conducted so far points towards NMDA receptors playing an important role in LPT 
and thus in forming our memory. This leads to the conclusion, that malfunctions of 
the receptor may be occurring in dementia connected illnesses like Alzheimer’s. [74] 
The mapping of NMDA receptors would enable to better understand and influence 
the function of the receptor. 
1.8.3.1 NMDA receptor agonists 
The two most important agonists of the NMDA receptor are the salts of glutamic acid, 
which dissociates in the body to glutamate, and N-methyl-D-aspartate (NMDA), the 
structures of which are shown in Figure 1.9. Most other important agonists are based 
on these structures, but there has been no completely new approach towards the 
synthesis of NMDA agonists during the past years. 
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L-glutamic acid  N-methyl-D-aspartate (NMDA) 
Figure 1.9: Structure of the two most important NMDA receptor agonists 
1.8.3.2 NMDA receptor antagonists 
Antagonists of the NMDA receptor show great influence on the psychological 
behavior of the user, an example being two compounds well-known under their 
aliases Angel Dust and Special K. 
 
 PCP (Angel Dust)  Ketamine (Special K) 
Figure 1.10: NMDA receptor antagonists that are misused as street drugs 
Both are considered dissociative drugs, which induce a state in which the conscious 
mind is disconnected from the rest of the brain. While a lot of other drugs also show 
similar effects dissociative drugs also produce effect like sensory deprivation, 
hallucinations as well as dream-like states and trances. [75] Similar effects can be 
witnessed with most of the NMDA receptor antagonists, which makes clinical 
application difficult. On the other hand both, ketamine and PCP, show effects on 
other receptors and are not selective for the NMDA receptor only, which may explain 
the dire effects they have. Abuse of both drugs leads to cognitive impairment 
(e.g. confusion, forgetfulness and difficulty to concentrate) and possibly cell death, 
resulting in lasting memory problems. 
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 a) CCP b) Ifenprodil 
Figure 1.11: Examples of a) competitive and b) non-competitive antagonists of 
NMDA receptors 
Most antagonists that have been developed during the last years are either selective 
for the NR2A (for example CCP) or the NR2B (for example Ifenprodil) subtype 
(cf. Figure 1.11), while only few compounds exist that show selectivity for NR2C or 
NR2D. This is due to the higher interest in NR2A and NR2B selective antagonists, 
since these subtypes are more common and more important in mammalian brain. 
A different method of antagonism, called uncompetitive or functional antagonism, is 
witnessed with the so called channel blockers, molecules which do not associate with 
the receptor but block the receptor channel itself. One of these channel blockers, 
memantine, has already found application in patients with Alzheimer’s disease and is 
currently in research for other applications. [76] 
 
Memantine 
Figure 1.12: Memantine, an NMDA channel blocker 
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1.9 NMDA receptor ligands with amidine structure 
The development of radioligands for studying the human brain by means of emission 
tomographic methods is of high interest. Especially those for the NR2B sub-system of 
the NMDA receptor family have come into focus during the last years. In 2003 a 
Merck group published a series of new compounds with benzamidine structure that 
act as antagonists of the NMDA receptor with a very promising affinity (low ki-values), 
allegedly high metabolic stability and a good permeability into the brain. [77, 78] First 
radiolabeled NMDA receptor ligands with amidine structure were synthesized in 2005 
and 2006. [79, 80] Labeling of these compounds was performed using tritium, 
fluorine-18 or carbon-11. [79, 80] While good selectivity was shown in vitro, no data is 
known on the in vivo evaluation of those radiolabeled compounds, besides for the 
carbon-11 derivatives, which exhibited a high metabolization rate in vivo. [81] 
Compound 1, depicted in Figure 1.13, had previously been published and had shown 
a very good ki-value of 0.5 nM. 
[77] The ki-value of compound 2 showed equally low 
values and suggests labeling of the compound achievable. While substance 2 was 
originally labeled using the [11C]methyl group, the [18F]fluoroethyl group would offer a 
good alternative for labeling with fluorine-18. The attributes of these two groups are 
similar enough that steric and electric properties of the molecule would be changed 
as little as possible. Radiolabeling of the compound could be performed indirectly via 
2-[18F]fluoro-1-bromoethane. This type of labeling via a prosthetic group seems 
promising, as the structure of compound 1 is similar to the planned labeled product. 
1 2  
 ki = 0.5 nM ki = 0.7 nM 
Figure 1.13: Cinnamamidines synthesized by Curtis et al. (1) and Thominiaux et 
al. (2) [77, 80] 
In 2006 a publication by Årstad et al. gave first in vivo results for carbon-11 labeled 
compounds including derivative 2, which showed low metabolic stability of most of 
the benzamidine compounds while ki-values were good (0.7 nM for 2) and brain 
permeability was promising. [81] 
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When a publication by Nguyen et al. in 2007 first set a spotlight on cyclic amidines, it 
was shown that those compounds promise better stability in vivo and at the same 
time have similar ki values to the benzamidine compounds. 
[82] 
Central functional groups in these compounds are two structures that have been 
under research for more than a hundred years: salicylates and amidines. 
Willow bark had been known to reduce fevers and ease pain since at least the 5th 
century B.C., but it was not until 1826 that Johann Andreas Buchner was able to 
extract the compound that caused the activity of the bark: salicylic acid. By the end of 
the 19th century the development of the new compound into a useable drug had been 
accomplished, when Bayer introduced Aspirin® to the market. Since then a wide 
range of salicyl derivatives have been under research for different uses. 
Pharmaceutical chemistry would be different without it. Many structures derived from 
natural compounds contain an aromatic ring that carries a hydroxyl group in 
2-position to an aldehyde, carboxylic acid or methylamine moiety, for example, thus 
making salicylates an important synthon for organic synthesis. 
Discovery of the mechanism of how acetylsalicylic acid works in the human body was 
published in 1971 by Robert John Vane. [83] In 1982 Vane received the Nobel Prize 
for Physiology or Medicine for the discovery how acetylsalicylic acid inhibits 
prostaglandin synthesis. 
While salicyl compounds have been under constant investigation, amidines have not 
been in the focus of research until the end of the 19th century, when Adolf Pinner 
described the synthesis of imidates. [84] His work was the first to describe the 
synthesis of this functional group and while it may not be one of the most important 
groups in organic chemistry, it can be applied as useful intermediate in many multi 
step syntheses. [85] Amidines can generally be easily synthesized from the nitril by 
reacting it in a suitable solvent (benzene, chloroform, ether or ethanol) at 0 °C with 
HCl gas. The imidate that will form can either be separated as the imidoester or 
reacted with anhydrous ammonia or ammonium cloride to give the amidine as 
hydrochloric salt, while reaction with water will give the ester. [85] A wide range of 
amidines is contrivable and the Pinner synthesis has found wide use especially in 
modern day chemistry with the commercial availability of hydrogen chloride gas. 
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2 Aims and scope 
The special role of fluorine-18 in radiopharmaceutical chemistry has been 
demonstrated by many examples. Meanwhile numerous radioligands exist for in vivo 
studies of the various receptor systems, but only few suitable ones are known for the 
glutamatergic receptor system. The radiosynthesis of a n.c.a. receptor ligand labeled 
with fluorine-18 therefore is of high interest to enable further studies on glutamate 
receptors. 
As described in the introduction several organic molecules with a benzamide 
structure have been proven to be good ligands for the NMDA receptor. While the 
selected lead structure had already been labeled using carbon-11, in the scope of 
this work labeling with fluorine -18 is planned in order to enable extended studies. 
Based on the lead structure, compounds were therefore chosen as target molecules, 
which can be radiofluorinated with high specific activity for possible use as in vivo 
radioligands of NMDA receptors. 
All molecules show similar structures, three of them (3, 4, 5, see Figure 2.1) differing 
only in the kind of the spacer between the phenyl ring and the amidine. The forth 
compound 6 shows a cyclic amidine structure that promised better in vivo stability. 
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Figure 2.1: Radiolabeled benzamidines that are to be synthesized in the scope of 
this work 
The first task to fulfill is the synthesis of the labeling precursors and of the authentic 
target compounds to be used as chromatographic standards for identification of the 
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no-carrier-added labeled compounds. Synthesis of both can partially follow routes of 
production described in the literature. Accordingly, it is planned to synthesize 
2-hydroxybenzylamine and react it with a selected imidoester in a base assisted 
coupling reaction to form the desired amides. The imdoesters are planned to be 
obtain from the respective nitriles. The cyclic compound 6 should be synthesized 
from benzylamine and 2-(bromomethyl)-benzonitrile. 
The authentic standard compounds have to be produced by alkylation of the 
corresponding labeling precursor previously synthesized. Introduction of 
1-bromo-2-fluoroethane into the molecule should be attempted by using a base and 
possibly sodium iodide as co-reagents. 
Once both compounds (precursor and the fluoro-compound) have been synthesized 
in pure form, the 18F-labeling reaction on the precursor can be established. Labeling 
reactions of phenols with 1-bromo-2-[18F]fluoroethane have been described in 
literature and it is planned to follow those generally. A possible alternative to a 
labeling reaction starting from a bihaloalkane is the use of double functionalized 
glycols, especially ethylenglycole-1,2-ditosylate. 
Optimization of the labeling reaction needs to be performed once it has been 
confirmed that the chosen method of labeling is generally feasible. Optimization with 
respect to time, solvent and temperature will be of foremost importance. Further 
optimization will comprise the concentration of precursor and base, as well as a 
variation of the base used. 
In order to analyze the labeled products and to determine their radiochemical yield it 
is necessary to establish chromatographic systems for both (radio-) thin layer 
chromatography and (radio-) high performance liquid chromatography (HPLC). For 
determination of the specific activity of the labeled compounds the detection limit of 
the HPLC has to be determined of the corresponding authentic standards. 
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3 Results and discussion 
3.1 Organic synthesis of precursors and fluoro-compounds 
While several compounds with benzamidine structure were to be synthesized in the 
course of this work, a model compound was chosen to establish the reaction 
conditions. Cinnamylnitril 7 was deemed a good choice, since several publications 
about its synthesis and chemical and metabolic properties and those of similar 
compounds have been published. [79, 80, 81] The course of reaction for synthesis of 
those compounds was originally planned as according to Scheme 3.1. 
11 R = cinnamyl
16 R = 2-naphthyl 
17 R = benzyl
K2CO3/Acetone
  7 R = cinnamyl
12 R = 2-naphthyl 
13 R = benzyl
  8 R = cinnamyl
14 R = 2-naphthyl 
15 R = benzyl
BrEtF
11 R = cinnamyl
16 R = 2-naphthyl 
17 R = benzyl
3 R = cinnamyl
4 R = 2-naphthyl 
5 R = benzyl
DMF
HCl
Pd/C, H2
NEt3
EtOH
MeOH
9
10
 
Scheme 3.1: Concept of reaction path for the non-cyclic labeling standards 3 – 5 
For the model compound synthesis of the authentic standard 3 started with a Pinner 
reaction in ethanol to form the imidoester 8, this was coupled with salicylamine 10, 
obtained by reduction of 2-hydroxybenzonitrile, to give the labeling precursor 11. This 
was then to be alkylated to give the final product 3. 
Other compounds synthesized were the labeling precursors 16, 17 and 19 and the 
corresponding standard compounds 4, 5 and 6 (cf. Scheme 3.1 and Scheme 3.2). 
With these additional compounds the structure was only slightly modified. While 
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compound 17 lacks the spacer between the phenyl ring and the amidine, in 16 a 
naphthyl group is introduced that stabilizes the linker and adds steric hindering. All 
these structures are known to be metabolically unstable, [81] what lead to the 
introduction of a different molecule into this work, the cyclic compound 6. 
EtOH
base
BrEtF
18
19
6
10
 
Scheme 3.2: Reaction pathways for the cyclic compound 6 synthesized in this work 
The labeling precursor for this molecule is compound 19, a cyclic amidine that is not 
synthesized in a Pinner like reaction but in a simple condensation reaction with the 
hydroxybenzylamine.  
Cyclic amidines have been evaluated by Nguyen et al. and showed very promising 
results. [82] The plasma half-life for one these compounds (20, cf. Figure 3.1) was 
measured and reported to be about 2 hours. This compound was subsequently 
chosen as model for the synthesis of cyclic amidine 6. 
20  
Figure 3.1: Lead structure for the cyclic amidine 
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3.1.1 Synthesis of 2-hydroxybenzylamine 
Synthesis of 2-hydroxybenzylamine 10 was previously described in various 
publications. [86, 87, 88] In those studies synthesis was performed using either the 
salicyloxime or the salicylamide, which are commercially available or easy to 
synthesize. The pure compound is also available commercially, but prices are very 
high (1 g > 150 Euro) and due to the amount needed in the course of this work, it was 
decided to synthesize 10. 
In addition to having the target compound carry the hydroxyl-group in 2-position (10), 
the compound carrying the hydroxyl-group in 3-position (22) was to be synthesized. 
The variation of the position and the subsequent change of ki-values were considered 
to be of interest. This plan was not followed when synthesis of the 2-hydroxy 
compounds proved more demanding than expected and at the same time the 
3-hydroxy compound was expected to be metabolically less stable. While 
establishing the reaction pathways still a method of synthesis was searched that 
could be used for both compounds. Since neither 3-hydroxybenzylamide nor 
3-hydroxybenzylaldoxime are commercially available, the benzonitrile 21 was chosen 
as starting compound (cf. Figure 3.2). 
9 21  
Figure 3.2: Benzonitriles for the synthesis of benzylamines 
A common method for the reduction of nitrile groups is the use of hydrogen and 
palladium on active charcoal (Pd/C) in methanol. The reagent is dissolved in 
methanol and Pd/C is added, and the reaction is either done under hydrogen 
atmosphere or under argon atmosphere with the addition of ammonium formate. [89] 
Under these conditions the formate decomposes into hydrogen, carbon monoxide 
and ammonia and thus acts as a hydrogen donor. Since this method of reduction is 
easy and generally gives excellent yields, it was the first choice. 
Reaction with methanol as solvent, using a hydrogen gas atmosphere and 
2-hydroxybenzonitrile 9 as reagent, did not give the desired product, even though 
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reaction was complete and a control by thin layer chromatography (TLC) showed 
only a single product. An analysis with mass spectroscopy proved that dibenzylamine 
was the sole product. Further methods of synthesis utilizing a Pd/C system, but using 
ethanol instead of methanol as solvent or adding ammonium formate also gave no 
product. Analysis with TLC once again showed one product and no traces of reagent 
left, but mass spectroscopy confirmed the product to be dibenzylamine. 
Literature indicates other options for synthesis: the use of complex metal hydrides, 
like lithium aluminium hydride (LAH), or borane (in either dimethyl sulfide or 
tetrahydrofuran) as reducing agents. [90, 91, 92] 
LAH is often utilized in today’s chemistry as a useful and widely applicable reagent 
for hydration reactions. Depending on reaction conditions it can be used to reduce 
esters or carboxylic acids to primary alcohols (offering a feasible alternative to the 
Bouveault-Blanc reduction) or nitriles to the corresponding amine. During this work 
syntheses with LAH were done both with and without the addition of aluminium 
chloride, the latter improving the formation of free aluminium hydride in the solution. 
Both reactions showed a product in TLC control, but mass spectroscopy showed that 
a different product than the desired one was obtained. 
At this point a problem with analysis was presumed and therefore the compound was 
acquired commercially and tested with mass spectroscopy. The method of analysis 
was slightly changed and synthesis of the amine was repeated using the conditions 
with Pd/C in methanol and hydrogen gas (cf. Scheme 3.3). 
21
Pd/C
MeOH
22  
Scheme 3.3: Synthesis of 3-hydroxybenzylamine (22) 
Surprisingly the 2-hydroxy compound did not yield any product, while the 
3-hydroxybenzylamine (22) could be isolated in very good to quantitative yields. It 
remains unclear why the reduction of 9 was not successful, but several further 
attempts and control by mass spectroscopy confirmed that the dimer was the sole 
product formed. 
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As alternative method of synthesis a reaction path using borane in THF was 
developed. This reaction pathway provided the product 10 while offering simple 
reaction conditions and short reaction times. The reagent was dissolved in THF and 
reacted with borane under reflux. After 3 hours reaction was stopped by adding 
aqueous HCl and the product was extracted from the solution. [92] These reaction 
conditions have been established by Brown et al. as simple and rapid giving excellent 
yields for a wide range of nitriles. While the reaction proceeds only slowly if borane is 
added in equimolar amounts or at lower temperatures (0 °C), an excess of borane 
and higher temperatures give the desired product in good yields after reaction times 
of a few hours. Reduction is selective for the nitrile even in the presence of (less 
reactive) functional groups. [93] 
 
Scheme 3.4: Possible intramolecular formation of a salt. 
Thus, the desired product 10 was obtained, though yields varied greatly and were 
less than expected (41 - 69 %). A possible explanation for this could be the 
intramolecular formation of a salt (cf. Scheme 3.4). Since the product had to be 
extracted from an aqueous solution, it can be assumed that a part of the salt 
remained in the aqueous layer and could not be extracted with an organic solvent. To 
prevent this, the solution was set to both acidic and basic pH values and extraction 
was done, but at neither pH = 1 nor pH = 10 were better yields found. 
3.1.2 Synthesis of precursors 
For the preparation of the model compound 3 the cinnamyl precursor 11 was 
synthesized in a 2-step reaction, starting from (E)-cinnamyl nitrile 7, following 
instructions published by Thominiaux et al.. [80] In addition to this compound the three 
other labeling precursors 16, 17 and 19 were synthesized as described by Årstad et 
al. and Nguyen et al.. [81, 82] Further as an alternative to indirect labeling via prosthetic 
groups an attempt at synthesizing a precursor for direct labeling was made as 
described in chapter 3.1.2.4. 
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3.1.2.1 Synthesis of N-(2-hydroxybenzyl)cinnamamidin (11) 
As first step in the synthesis of the cinnamyl precursor the nitrile 7 was transformed 
to the corresponding imidoester 10 by a Pinner synthesis (see Scheme 3.5). The 
reagent was reacted in ethanol at 0 °C with hydrogen chloride gas. Monitoring by 
TLC showed completion after 18 hours reaction time. The reaction was left standing 
at room temperature, which allowed a colorless to cream colored precipitate to be 
formed. This generally took between one and two weeks and is the usual method of 
synthesis for a Pinner reaction. 
10
7 8
11
HCl
EtOH
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Scheme 3.5: Method of synthesis of N-(2-hydroxybenzyl)cinnamamidin (11), 
A: NEt3, DMF; B: NaOCH3, MeOH 
The solid was isolated from the solvent by filtration. After drying, the ethyl 
cinnamimidate hydrochloride was obtained in excellent yields (>90 %). No formation 
of the ortho ester was observed, even though it is a known side reaction, if ethanol is 
used as a solvent. [86] 
The obtained product 8 was further reacted without purification and coupled with 
2-hydroxybenzylamine (10) in DMF with triethylamine as base to give 
N-(2-hydroxybenzyl)cinnamamidin (11) in a wide range of yields (22 - 77 %; 
method A, see Scheme 3.5). 
Method B for the synthesis of 11 was published by Årstad et al., who used sodium 
methanolate as base. [81] For this reaction the 2-hydroxybenzylamine 10 was 
dissolved in methanol and solid sodium methanolate was added. After addition of the 
ester the reaction was stirred at room temperature until control by TLC confirmed the 
completion of the reaction. After 12 to 18 hours of reaction time the reaction was 
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quenched and the solvent was evaporated in vacuo. After removal of the solvent the 
raw product was obtained as a light orange to cream colored solid in quantitative 
yields and purified by crystallization. 
Both methods of reaction were employed and the product was used for further 
reaction if mass spectrometry confirmed that the product was sufficiently pure 
(> 95 % by mass). 
Only if the product was to be applied as labeling precursor was a second 
crystallization performed. This lowered the yields significantly but gave a perfectly 
clean product (> 99 % by HPLC) that formed light yellow crystals. 
3.1.2.2 Synthesis of N-(2-hydroxybenzyl)naphthylamidin (16) and N-(2-hydroxy-
benzyl)benzylamidin (17) 
In order to synthesize the naphthyl and phenyl compounds the respective 
imidoesters were formed in a pinner synthesis that followed the conditions given in 
chapter 3.1.2.1. Both imidoesters were obtained in excellent yields above 90 % and 
used without further purification. 
HCl
EtOH
R = 2-naphthyl 12 
R = phenyl       13
R = 2-naphthyl 14 
R = phenyl       15 
R = 2-naphthyl 16 
R = phenyl       17
10
base
 
Scheme 3.6: Synthesis of precursors 16 and 17 
For synthesis of the compounds 16 and 17 method A using NEt3 as described in 
chapter 3.1.2.1 was applied (cf. Scheme 3.6). Surprisingly no product could be 
obtained with both compounds following these instructions. Significantly, no 
precipitate formed when the imidoester was stirred with NEt3. Even though it is not to 
be expected, one must consider whether or not the salt remaining in a solution did 
have a negative effect on the reaction. Since alternative reaction conditions had been 
given by Årstad et al. and had already proven successful in the synthesis of 11, it 
was not tried to optimize method A and instead method B was applied. [81] Synthesis 
using method B proceeded without problems and gave products 16 and 17 in 
quantitative yields. All reagents were stirred under argon at room temperature in until 
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TLC confirmed completion of the reaction, whereupon the reaction was quenched 
and the solvent was evaporated in vacuo. 
The raw product was crystallized from methanol at least twice, if it was supposed to 
be used as labeling precursor, in order to ensure highest purity. While minor 
contaminations of by-products usually do not impact organic reactions on 
macroscopic scale, even the smallest amounts of other compounds can cause the 
formation of by products during radiolabeling reactions. Therefore purification by 
crystallization from a suitable solvent or flash-column chromatography, if 
crystallization is not possible, is normally applied. After crystallization the naphthyl 
precursor 16 was obtained in high purity (> 99 % by HPLC) but in yields of about 
43 %, while the phenyl precursor 17 was obtained in yields of approximately 25 % in 
similar high purity (> 99 % by HPLC). The loss in yield is high and thus should be 
avoided if the product is used in any other reaction than a labeling reaction. 
3.1.2.3 Synthesis of N-(2-hydroxybenzyl)-isoindoline-1-imine (19) 
EtOH
70 °C
3h
1018 19  
Scheme 3.7: Synthesis of N-(2-hydroxyethoxybenzyl)-isoindoline-1-imine (19) 
The synthesis of the cyclic amidine precursor 19 was performed as described by 
Nguyen et al. (cf. Scheme 3.7). [82] 
2-Hydroxybenzylamine (10) was dissolved in ethanol and equally dissolved 
2-(bromomethyl)-benzonitrile (18) was added to the solution which was then heated 
to reflux. Control with TLC showed a good conversion rate and after 3 hours the 
reaction was stopped by removal of solvent and the solid residue purified by 
crystallization. The product was obtained as light yellow needles in very good yields 
(75 %) and high purity (> 98 % by HPLC). 
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3.1.2.4 Synthesis of N-(2-toslyoxyethoxybenzyl)cinnamamidine (27) 
The labeling precursor 27 for a direct labeling reaction by substitution with 
[18F]fluoride had to be synthesized in 4 steps starting from cinnamylimidoester 7 and 
salicylaldehyd 24 (see Scheme 3.8). While generally reaction conditions for 
production of amidines from imidoesters need to be water-free, a method was used 
that tolerates small amounts of water and will give the amidines in good yield. [94, 95] 
The imidoester was transferred into the amidine by stirring with triethylamine and 
ammonium chloride in ethanol. The reaction proceeded as planned and gave the 
desired product 23, which was obtained as colorless needles in low yields (17 %). 
The tosylated salicylaldehyd 26 was synthesized similarly to the fluoroethoxy 
compound by first coupling 2-bromoethanol with the salicylaldehyd 24 in DMF using 
cesium carbonate as base. After column chromatography the product 25 was 
obtained in quantitative yields as brown oil. 
Tosylation of the alcohol was performed in a quickly proceeding reaction with tosyl 
chloride, trimethylammonium chloride and triethylamine in dichloromethane (DCM). 
After 1 hour of reaction time the control TLC showed no remaining reagent. The 
tosylated compound 26 was obtained as light yellowish to brownish crystals in good 
yield (75 %). 
Before synthesis of the final amidine compound 27 it was examined if a coupling by 
reductive amination would be possible, and if so, which conditions would be mild 
enough to allow the use of a tosylated compound. A publication from 1901 showed 
that the reaction of amidines to Schiff bases is generally possible under mild 
conditions. [96] The reaction was subsequently planned following these conditions but 
no product was found even after prolonged reaction times. As an alternative the 
reduction of the Schiff base to the desired product 27 was conducted according to 
methods given by Abdel-Magit et al.. [97] 
Sodium triacetoxyborohydride, a very mild reducing agent, was utilized, which is 
easily employable, since the substance is not sensitive to air and moisture. 
Synthesis of N-(2-tosyloxyethoxy)cinnamamidine (27) was attempted by coupling of 
the amidine 23 and the aldehyde 26 in DCM under mild heating in the presence of 
sodium triacetoxyborohydride in order to reduce the produced imine. The reaction 
time was 7 days and a product was obtained as a colorless solid. Mass spectrometry 
proved, however that the product was not the desired precursor. 
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Scheme 3.8: Method of synthesis of the precursor 27 for a direct labeling reaction 
Therefore, it was tried to couple the amidine and aldehyd as described by Kunckell et 
al..  [96] When after a day of reaction time no conversion was noticed, equilibrium of 
the reaction was shifted by adding 4Å molsieve and the reaction was stirred for 
another 8 hours. Again no reaction product could be found by TLC and one 
equivalent of formic acid was added to catalyze the reaction. After another 16 hours 
the reaction was stopped since no product could be found. It was concluded that 27 
cannot be produced in the way described in Scheme 3.8. This is different from the 
findings of Kunckell et al., who reported a fast reaction between benzylamidine and 
salicylaldehyde. [96]  
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3.1.3 Synthesis of the authentic fluoro-compounds 
It is necessary to synthesize the target molecules 3 - 6 containing a stable fluorine 
atom. Besides employing those as standards for establishing a chromatographic 
system, they sometimes are also used as carrier. This is of great importance since 
molecules under n.c.a. conditions often show different characteristics than expected 
and adding carrier to the solution containing the labeled molecule may help verifying 
the identity of the product. The authentic standard compound is further used for 
biological evaluations in order to establish systems for further in vitro and in vivo 
studies. 
While all the precursor molecules could be prepared by methods described in the 
literature, no paper has been published to date containing molecules of this type that 
are fluoroethyl-substituted at the hydroxyl group. Therefore standard reaction 
conditions were applied that had succeeded at the introduction of the desired 
functional group in other molecules containing an arylic hydroxyl group. 
3.1.3.1 Direct methods 
11 3
Base
 
Scheme 3.9: General method of synthesis of 2-fluorethoxybenzylcinnamamidine 3 
Generally, reactions of functionalized alkanes with arylic hydroxyl functions are 
simple methods of introducing a wide range of functional groups. Often the presence 
of a hydroxyl and an amine function leads to disubstituted products. In this molecule 
it was expected that the amidine group would slightly deactivate the amine and the 
higher acidity of the hydroxyl group would lead to a single product. Therefore 
standard reaction conditions for the introduction of 1-bromo-2-fluoroethane (BFE) into 
an aromatic molecule were chosen (cf. Scheme 3.9). While following this approach, a 
range of different reaction conditions was tested, which are listed in Table 3.1. 
A reaction at room temperature using potassium carbonate as base and acetone as 
solvent was employed (cf. Table 3.1, entry 1). These conditions are generally 
considered favorable, since normally no or very few by-products are observed and 
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the carbonate can be removed by filtering after the reaction is completed, thus 
simplifying workup considerably. The reaction was monitored by TLC and when after 
24 hours no product could be found in the reaction mixture, the temperature was 
increased and additional equivalent of 1-bromo-2-fluoroethane was added. After 
2 days of stirring under reflux no reagent was left as confirmed by TLC and the 
reaction was stopped. After removing the solvent the obtained solid was analyzed 
with mass spectroscopy, but the desired product could not be found. 
Table 3.1: Reaction conditions for the synthesis of 2-hydroxybenzylcinnamamidine 
entry Base Additions Solvent Temperature Yield 
1 K2CO3 - Acetone 25 °C - 
2 K2CO3 NaI Acetone 25 °C - 
3 K2CO3 - Acetone 60 °C - 
4 K2CO3 NaI Acetone 60 °C ~ 10% 
5 NEt3 - DMF 100 °C - 
6 NaOMe - Methanol 70 °C - 
7 NaOMe NaI DMF 70 °C Traces 
8 NaH - THF 70 °C - 
9 NaH - THF 0 °C- 70 °C - 
10 NaH - DMF 0 °C – 70 °C Traces 
11 NaH - MeCN 85 °C - 
12 KOH - DMSO 25 °C - 
13 KOH - EtOH 100 °C 50 %
a
 
14 Na2CO3 NaI 4-Methyl-2-pentanone 100 °C - 
15 K2CO3 NaI 4-Methyl-2-pentanone 100 °C - 
16 Cs2CO3 NBu4Br MeCN 25 °C - 
17 K2CO3 - DMF 120 °C 30 %
b
 
18 K2CO3 KI DMF 120 °C 70 %
b
 
a Product could not be separated since decomposition occurred during purification 
b Product contained both the O- and the N-alkyl compound, as shown by NMR. These isomers could 
not be separated 
In a second attempt (entry 2) a small amount of sodium iodide (NaI) was added to 
the solution to enable the in-situ formation of 1-iodo-2-fluoroethane, which is a better 
reactant. [98] While reaction at room temperature again gave no product, at 60 °C 
about 10% of product could be found in the solution as confirmed by mass 
spectroscopy (entry 4). 
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Since higher temperatures were expected to lead to both the N-alkylated and the 
O-alkylated product, it was decided to try reaction conditions at moderate 
temperatures using stronger bases. A stronger base should make deprotonation of 
the phenole more likely, which would reduce the possibility of generation of two 
products. It was expected that under the mild conditions the possible by-product, if at 
all, would only be produced in small amounts and that a separation of the two 
products would be possible, if necessary. 
An alternative to the use of carbonate as base was the comparably mild base 
triethylamine, which was utilized in DMF at 100 °C (entry 5). When control with TLC 
showed no unreacted compounds in the reaction solution after 24 hours the reaction 
was stopped and the product extracted with DCM, but only no product was found. 
As stronger base sodium methanolate was used directly with the BFE present in the 
solution. It was also tried to produce the sodium salt of the amidine first and add BFE 
after change of the solvent (entry 6 and 7). The reaction with the amidine in methanol 
at 70 °C did not give any product and while the sodium salt seemed to form readily, a 
reaction in DMF at 70 °C in presence of NaI did not give more than traces of product 
as determined by mass spectroscopy. 
Since the use of weak and medium bases seemed unsuccessful, the strong base 
sodium hydride was then utilized with THF, MeCN or DMF as solvent and at 
temperatures between 0 °C and 70 °C (entries 8 to 11). Reactions in THF and MeCN 
did not prove successful and a reaction in DMF gave only traces of the desired 
product. The starting compound could also not be found in the solution, and since 
mass spectroscopy did show a number of by-products with masses lower than that of 
the amidine, it was concluded that decomposition of the compound had taken place. 
In order to avoid decomposition a weaker base had obviously to be applied and 
potassium hydroxide was chosen (entry 12 and 13). As solvent DMSO and ethanol 
were employed and while the simple and direct reaction of the amidine in DMSO with 
NaI and BFE did not yield any product, formation of the potassium salt of the amidine 
and subsequent reaction in ethanol showed success, as about 50% product was 
found in the reaction solution (analyzed by mass spectroscopy). The product 
decomposed during the aqueous workup and could not be isolated, which pointed 
towards this method of reaction also not being favorably. 
Up to this point only the use of potassium carbonate and potassium hydroxide had 
given good results, which lead back to the use of carbonates as bases (entries 14 to 
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18). As an alternative to potassium carbonate, sodium and cesium carbonate were 
applied. Since reactions in acetone gave no product even after days of reaction, an 
alternative solvent that could be used at higher temperatures was employed. Both 
potassium and sodium carbonate were used with 4-methyl-2-pentanon at 100 °C, but 
again no product could be found. To be able to further rise the temperature DMF was 
used as a solvent at 120 °C. Under these conditions the reaction gave 30 % of the 
fluoroalkylated product which was cleaned by column chromatography and analyzed 
with mass spectroscopy and NMR (entry 17). 
The product still contained by-products that could not be removed with normal 
chromatographic methods. In an attempt to lower the rate of by-products reaction 
conditions were slightly altered by adding sodium iodide to the reaction, which gave 
very good yields (entry 18). The product was first cleaned by flash-chromatography 
and when this proved insufficient, by semi-preparative HPLC. The product was 
obtained in very small yields and analyzed using mass spectroscopy and NMR. While 
mass showed a clean product the 19F-NMR showed small residues of another 
fluorine compound that could not be removed chromatographically. Since HPLC was 
> 99 % pure, it seems reasonable to conclude that the other compound found is the 
N-fluoroethyl isomer. This pointed towards both isomers having very similar 
properties, thus making chromatographic purification very difficult. The direct 
approach showed little prospect of success and no further experiments were done. 
 
Figure 3.3: Potential deactivation of the hydroxyl group through formation of a 
hydrogen bond 
Generally reaction yields suggest that the hydroxyl group is not very reactive when 
positioned in ortho-position to the benzylamine. Reactions that were undertaken 
using the amine as a reagent showed low yields even under reaction conditions that 
are known to lead to good or very good results with other compounds. Normally the 
addition of a fluoroalkane to a phenole is a simple reaction that has been applied for 
many different reagents, and especially in radiochemistry is a standard reaction. 
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A possible reason for the reaction problems may be the formation of hydrogen bonds 
between the amine and the hydroxyl group, leading to formation of a stable ring, 
which could cause a deactivation of the oxygen atom (see Figure 3.3). At the same 
time it would normally be expected that the reaction takes place without hindrance, 
since deprotonation of the oxygen should be even facilitated. 
With all reactions using temperatures above 60 °C a high fraction of by-products 
could be found, but most of the time they were the only compounds produced. It is 
known that when heated 2-hydroxybenzylamine compounds decompose under 
formation of ortho-quinone methide (cf. Scheme 3.10). [99] The use of 
hydroxybenzylamines as protection groups for amines has been suggested and been 
successfully applied in literature. [100] However, temperatures at which such 
decompositions normally occur are at about 200 °C. Therefore decomposition was 
not expected to take place in the course of this work, but given the unfavorable 
results of several reactions, the possibility has to be considered. The amount of 
by-products found in the reactions was generally high and it could be discussed 
whether some kind of decomposition may have taken place. 
∆ R = alkyl,
       phenyl,
       benzyl
 
Scheme 3.10: Thermal decomposition of 2-hydroxybenzylamines 
Since ortho-quinone methide is a very reactive compound it would react with other 
molecules present in the reaction solution almost instantly. This would account for 
the wide range of different by-products found under strongly basic conditions. 
Analysis of the by-products with mass spectroscopy, however, did not point towards 
this, since the masses found could not be allotted to potential multimers of 
ortho-quinone methide. 
3.1.3.2 Indirect methods 
An alternative to the reaction of 1-bromo-2-fluoroethane with 2-hydroxybenzyl 
cinnamamidine was the protection of the amidine. Attempts were made to protect the 
amidine with a N-tert-butoxycarbonyl (Boc) group. Introduction of this protecting 
group into the molecule by reacting Boc-anhydride in triethylamine and 
dimethylformamide with the precursor molecule was not successful and since the 
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protection of amidines, even though described in literature, is difficult, it was decided 
to avoid the introduction of a protective group. 
3
9
10
29
7
28
N
H
O
F
NH
NH2
O
F
NH
F
O H
NH2
O H
F
F
O
OEt
LG
NC
LG
NC
+
+
+
 
Scheme 3.11: Possible retrosyntheses of 2-fluorethoxybenzylcinnamamidine 3 
(LG = leaving group) 
Attempts to introduce BFE directly into the cinnamamidine 11 had not given the 
expected results and a different approach had to be taken. Retrosynthesis indicated 
that an introduction of the fluoroethyl group might be done directly on the 
2-hydroxybenzylamine (10) (see Scheme 3.11). A possible method of synthesis was 
reaction of BFE with the 2-hydroxybenzylamine 10 followed by coupling to the 
imidoester 7. An alternative to that approach would be the alkylation directly at the 
benzonitrile 9 and following reduction to the amine. The conditions under which 
reduction of the nitrile to the amine takes place could lead to partial decomposition of 
the product and made a reaction at the amine 10 more promising. This was 
subsequently planned. 
Upon first attempts under simple reaction conditions with potassium carbonate 
(acetone at RT) did not give any product, more rigorous reaction conditions using 
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refluxing DMF and different bases (carbonates, methanolates, sodium hydride) were 
applied, however even under those conditions the unprotected compound 10 gave no 
product at all. 
Since previous experience had shown that the formation of both possible alkylation 
products might be expected under harsh reaction conditions, the better alternative to 
use of stronger bases was a protection of the amine. The protected product would 
give only a single product since the nitrogen would not be available for reaction. At 
the same time it was estimated that functionalization of the amine would reduce the 
strength of the presumed hydrogen bond in the molecule enough to enable a reaction 
easily to take place (cf. 3.1.3.1 for further discussion). 
The simplest way to protect the amine 10 was the transformation into a Schiff base 
(see Scheme 3.12). The reduced basicity of the imine should inhibit the formation of 
an intramolecular hydrogen bond and therefore enable better reaction conditions for 
the alkylation. 
BFE, base
DMF 1. BFE, base
    DMF
2. HCl
31
30
28
10
tolylaldehyde
toluene
 
Scheme 3.12: Planned methods of synthesis of 2-fluorethoxybenzylamin (28) 
The imine 30 was produced by reacting 2-hydroxybenzylamine 10 with p-tolyl 
aldehyde in toluene. The desired product was readily obtained in good yields (43 % 
to 77 %) after 3 hours of reaction time. 
The plan was to introduce the fluoroalkyl group into compound 30 and then to 
deprotect the amine 31 without intermediate purification to give 28. For this reaction 
the imine 30 was reacted in DMF with potassium or caesium carbonate as base. 
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After the reaction the product was extracted, the solvent evaporated and the residue 
dissolved in ethyl acetate. After deprotection with HCl, no product could be found. 
Since the reaction did not proceed as expected, the reaction pathway was changed 
attempting to separate and analyze the alkylated product before further reactions. 
However, it was found, that the desired fluoroalkylated imine 31 was not formed as 
expected. Reaction conditions were varied by addition of potassium or sodium iodide, 
but still the desired product 31 could not be found. 
Formation of both the lithium and potassium salt of 30 was done, but a reaction with 
BFE using different carbonates in DMF did not yield any product. The fact that the 
imine 30 did not yield any product contributed to the above mentioned hypothesis 
that the formation of a hydrogen bond does deactivate the molecule, even though 
intramolecular formation of a true salt is not expected in this molecule. The fact that 
product 31 could not be found in mass spectrometry and TLC, even after reactions 
under harsh reaction conditions, even though no reagent was present anymore, 
implies that other problems than simply hindered reaction conditions occur. It is 
possible that the alkylated product 31 is formed during the reaction, but decomposes 
during workup. Different methods of obtaining the product 31 were attempted but 
were also unsuccessful. 
DMF, 40 °C
DCM
TFA
MsOC2H4F
Cs2CO3
Boc-NH2
TosNa
HCO2H
NaBH4
THF
MeOH/H2O
3524 34
2836  
Scheme 3.13: Pathway of synthesis for 2-fluoroethoxybenzylamine 28 
Generally the reaction conditions described in Scheme 3.12 should have given the 
desired product 28, as the reaction has been described on a similar 4-hydroxy 
compound in the literature good yields were obtained. [101] 
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In order to remove the potential problem of the intermolecular hydrogen bond it was 
decided to change the synthesis precursor and salicylaldehyde was used as starting 
compound (cf. Scheme 3.13). Reaction conditions were similar to those given by 
Bernacka et al..  [102] 
Due to changes in regulations 1-bromo-2-fluoroethane is not available commercially 
anymore. An alternative was 2-fluoroethylmesylate 33, which was synthesized from 
2-fluoroethanol (32) and methanesulfonyl chloride in a quick and easy reaction that 
gave good yields of 82 % to 88 % (see Scheme 3.14). 
The mesylate was then reacted with salicylaldehyde 24 and caesium carbonate at 
40 °C in DMF (cf. Scheme 3.13). [103] The resulting 2-fluoroethoxybenzylaldehyde 34 
was obtained in yields between 57 % and 73 %. The fact that the reaction did 
proceed without problems under mild conditions seems to support the theory that an 
intramolecular interaction takes place in the benzylamine. Only harsh reaction 
conditions gave comparable results for the synthesis of 3 starting from 11 (cf. Table 
3.1), and no product had been found after a reaction on 10. At the same time this 
hypothesis cannot be proven satisfactorily, since examples for similar problems could 
not be found in literature as encountered in this work. 
MsOCl
NEt3
DCM
32 33  
Scheme 3.14: Synthesis of 2-fluoroethylmesylate (33) 
Product 34 was purified by flash-column chromatography with ethyl acetate/hexan 
3/7 (v/v) as eluent and then employed in the next step. 
Introduction of the nitrogen into molecule 34 was conducted by a reaction of the 
aldehyde with tert-butylcarbamate (cf. Scheme 3.13). The reaction was employed, 
using water and methanol as solvents, with a simple reductive amination taking 
place. The amination is slightly changed in comparison to normal reaction routes by 
adding sodium toluene to the reaction. The sulfonate prevents the formation of an 
imine by addition to the carbon atom in the last reaction step giving the tosylated and 
Boc-protected amine 35 as a light yellow to colorless solid in good yields of 54 % to 
79 %. The solid precipitated during the reaction and was obtained by filtering off the 
solvents. 
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Removal of the tosyl group from 35 was achieved by a reaction with sodium 
borohydride in THF at room temperature. In this reaction the hydride acts both as 
base and reducing agent, first inducing an elimination reaction that removes the 
tosylate and then reducing the resulting Boc-protected imine to the Boc-protected 
amine. The reaction proceeded easily with good yields between 87 % and 94 % and 
after crystallization from ethyl acetate product 36 was obtained as colorless needles. 
Deprotection of the amine 36 to yield 28 was done under standard conditions with 
DCM and trifluoroacetic acid (TFA) in a 1/1 mixture (v/v) at room temperature. The 
product 28 was purified by flash-column chromatography with ethyl acetate and 
dipropylamine (8/2, v/v). Purification was difficult since column chromatography did 
not remove all traces of by-products and dipropylamine from the eluent could also not 
be completely removed after the column chromatography. Product 28 was therefore 
reacted in the next step without further purification. 
R =                  15 R =                  5
R =                  14
(i-Pr)2NEt
THF
R =                  4
28
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Scheme 3.15: Synthesis of the authentic standard compounds 3, 4 and 5 
Coupling between the 2-fluoroethoxybenzylamine (28) and the respective imidoester 
was achieved in THF using Hünig’s base (cf. Scheme 3.15). The reaction proceeded 
at room temperature with moderate yields. The resulting product was purified by 
repeated column chromatography and in the case of cinnamamidine (3) by 
crystallization from ethanol and water. The two compounds 4 and 5 obtained by this 
way could not be crystallized from any of the classic solvents and were thus only 
obtained as viscous oils. 
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Scheme 3.16: Synthesis of the authentic standard compound 6 
The cyclic compound 6 was obtained after reacting the benzylamine with 
2-(bromomethyl)-benzonitrile (18) in ethanol (see Scheme 3.16). After removal of 
solvent and crystallization the product was obtained as a white solid. 
3.2 Radiosynthesis of fluorine-18 labeled compounds 
Labeling of organic molecules with fluorine can be achieved under several different 
conditions. Radiofluorine can be produced in both electrophilic and nucleophilic form 
and labeling reactions are possible directly on the precursor molecule or by 
synthesizing a synthon that is then reacted with the precursor (cf. chapter 1.6). 
For the lead compound a labeling reaction with [11C]methyl triflate has been 
described by Thominiaux et al.. [80] Since a direct labeling reaction with [18F]fluoride 
could not be performed on the molecule due to missing activating groups, an indirect 
reaction pathway was planned. As shown in the introduction the utilization of a 
labeled synthon can be helpful with the synthesis of labeled molecules that cannot be 
obtained in a direct labeling reaction. In the past molecules that had previously been 
labeled successfully with a [11C]methyl group, often have been labeled with a 
[18F]fluoroalkane. The [18F]fluoromethyl group would normally be the first choice, but 
its handling is difficult and a fluoromethylene group bound to a heteroatom is often 
not stable. The [18F]fluoroethyl group is often employed instead. At the same time this 
group is promising, since electronic, steric and thus binding properties of the 
molecule will only marginally be changed compared to the [11C]methyl group. 
For this reaction most of the time one of the two reagents is used: either 
2-[18F]fluoroethyltosylate (FET) or 1-bromo-2-[18F]fluoroethane (BFE). For each 
reagent, new methods of radiosynthesis and especially work-up have been published 
during the last 10 years and a lot of advancement has been made towards simpler 
and better reaction conditions since the first publications highlighting these new 
labeling synthons. [45, 46] While Block et al. and other groups following them used a 
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HPLC separation of the labeled synthon, publications during the last few years gave 
examples for new methods successfully using solid phase exchange cartridges (SPE 
cartridges), that were also applied in this work. [104, 105] 
3.2.1 Production of 1-bromo-2-[18F]fluoroethane 
R = Br    37
R = Tos 38
R = Tf    39
[18F]40
K[2.2.2][18F]F
MeCN
 
Scheme 3.17: Labeling reaction of 1,2-dibromoethane with [18F]KF/Kryptofix 2.2.2 
1-Bromo-2-fluoroethane (40) is normally produced from three precursors: 
1,2-dibromoethane (37), 2-bromoethyl tosylate (38) or 2-bromoethyl triflate (39) (cf. 
Scheme 3.17). While the latter is not as widely used, it has been described in the 
literature for preparation of [18F]BFE [18F]40. [106] Another precursor that has been 
developed but not been widely introduced is 2-bromoethyl tosylate (38). [107] While 
the two sulfonic acid containing precursors promise to give better yields in the 
primary labeling reaction, 1,2-dibromoethane (37) is commercially available and 
easier to handle and therefore used for routine production in this work. The reaction 
conditions for the labeling reaction have been described in literature and were 
adjusted to our needs. [49, 104] 
As suggested by Block et al. the polar aprotic acetonitrile was employed as solvent 
for the primary labeling reaction. [45] This solvent gives best results for almost all 
labeling reactions and due to its lower boiling point and high volatility compared to 
DMF or DMSO is generally the best choice for labeling of alkyl derivatives, since it 
can be removed from the reaction easily, if necessary. 
Separation of the desired product from unreacted [18F]fluoride was done using a 
LiChrolut EN
®
 cartridge as first published by Comagic et al.. [49] The cartridge was 
preconditioned with methanol and water and the reaction mixture was slowly passed 
through it. The amount of reactivity fixated on the column corresponded to the 
amount of total product and varied largely between 25 % to 60 % radiochemical yield. 
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These large differences can be attributed to several possible reasons. If the cartridge 
was conditioned right before use yields generally were lower, while conditioning the 
cartridge up to 2 hours before the reaction was started showed better results. 
The product was eluted from the cartridge through a Waters AluminaB SPE cartridge 
to remove traces of water. Since the secondary labeling reaction was performed in 
either DMF or DMSO, the cartridge was conditioned with the respective solvent and 
the product eluted with 4 mL of DMF or DMSO heated to 70 °C. The amount of 
product obtained this way lay between 8 % and 45 % (decay corrected). 
Radiochemical yields lowered significantly in 2010 though the method of synthesis 
was not altered. Contamination of chemicals, solvents or other materials could be 
ruled out. Therefore the [18F]fluoride for synthesis was obtained from another 
cyclotron for a few days, to exclude a potential problem with the production of 
fluorine-18 at the Baby cyclotron. Surprisingly considerably better radiochemical 
yields were gained using the different fluoride. After verification of problems by other 
group members production at the Baby cyclotron was changed and radiochemical 
yields rose. 
After elution from the SPE cartridge the product was obtained radiochemically clean 
and no radioactive by-products were found as tested by HPLC. The radioactive 
product showed to peaks in HPLC that corresponded to the authentic standard for 
BFE, which also showed two peaks. This is probably due to the low pH of the HPLC 
eluent. The labeled [18F]BFE [18F]40 was used without further purification in the final 
labeling reaction. 
The complete reaction time was between 16 to 19 minutes from the moment of 
addition of the dibromoethane (37) to the fluoride complex until finishing the 
measurement of radioactivity in the collected fractions. Since fast reaction times are 
an absolute necessity for good yields with high specific activity, the use of SPE in 
comparison to the more time consuming HPLC separation proved crucial. With this 
way of synthesis the next step in the labeling reaction could be started within 20 
minutes from the start of the primary labeling reaction. 
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3.2.2 Production of 2-[18F]fluoroethyl tosylate 
41 42
MeCN
K[2.2.2][18F]F
 
Scheme 3.18: Labeling reaction on ethylenglycole-1,2-ditosylate (41) with 
[18F]KF/Kryptofix 2.2.2 
An alternative to dihalogenethane as precursor is ethylenglycole-1,2-ditosylate (41), 
which has been researched during the last 20 years. Just like 1,2-dibromoethane 
both ends of the alkane are functionalized. Since concentration of [18F]fluoride in the 
solution is very small compared to the concentration of the precursor, it is almost 
statistically impossible that a molecule disubstituted with fluorine-18 would be 
formed. As shown by Block et al. the labeling of the 1,2-bis(tosyloxy)ethane 41 with 
[18F]fluoride proceeds with better yields than that of the respective halogen 
precursors and gives the product 2-[18F]fluoroethyl tosylate (FET, 42) with a yield of 
about 82 %. [46] 
While in the late 1980s, with the beginning research on [18F]fluoroalkane prosthetic 
groups, the labeling precursor 41 had to be synthesized, it is now commercially 
available and can be used without further purification. However reaction times for the 
labeling reaction are longer than with 1,2-dibromoethane and until recently the 
product had to be separated from the precursor by HPLC separation, which caused 
longer times of synthesis. In 2007 a solid phase extraction of 
2-[18F]fluoroethyl tosylate was published by Honer et al.. [105] This method utilizes a 
tC18 cartridge and an AluminaN cartridge to separate the product from by-products 
and the labeling precursor. 
The labeling reaction (see Scheme 3.18) proceeds similar to the synthesis of 
1-bromo-2-[18F]fluoroethane, acetonitrile acts a solvent and the dissolved precursor is 
added to the dried [18F]fluoride. After the reaction the solution is dissolved with water 
and the product fixated on a Waters tC18 cartridge that is then rinsed with water. 
About 70 % of total radioactivity was found on the cartridge and could be eluted with 
tempered acetonitrile or DMF through an AluminaN cartridge. Radiochemical yield 
(RCY) was a bit higher than with the halogen precursor and lay at about 39 % ± 9 % 
(n = 2). 
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Reaction time from start of synthesis to measurement of radioactivity in the collected 
fractions was 25 minutes, which is significantly higher than for the synthesis with the 
dibromo precursor as described in chapter 3.2.1. 
3.2.3 Synthesis of N-(2-[18F]fluoroethoxybenzyl)-cinnamamidine 
(NaI)/(base)
[18F]BrEtF
11 [
18F]3  
Scheme 3.19: Labeling reaction as planned for the cinnamamidine compound [18F]3 
Introduction of the prosthetic group into the secondary precursor was planned 
following examples in several publications. [45, 49, 104] As shown by many groups, 
phenol can be labeled with BFE or FET in good yields. [45] Since nitrogen is also a 
potential site for labeling, depending on its basicity, it was considered if protection of 
the amidine group was necessary. After trials to protect the group were unsuccessful 
(cf chapter 3.1.2.2), labeling was tried without protection of the amidine, based on the 
consideration that the phenolic hydrogen is more acidic then the amidine hydrogen 
atoms and the oxygen will be deprotonated more easily than the amidine when a 
base is present. The pka of the phenolic group in 2-hydroxybenzylamine is roughly 8, 
while that of different amidines ranges between 12 and 30, with substituted amidines 
generally having a higher pKa due to their mesomeric stabilization. 
[108, 109]  
As first implemented for radiolabeling reactions by Zhang et al., sodium iodide was 
added to the reaction mixture in order to enable the in situ formation of 
1-iodo-2-[18F]fluoroethane that will be a better reactant than the bromo compound. [98] 
In a publication from 2003 Bauman et al. have published their results of a study on 
different iodides and reaction conditions. [104] Best results were found with lithium 
iodide followed closely by sodium iodide, while using MeCN, DMF and DMSO as 
solvents. It was therefore decided to use NaI of high purity and DMF as solvent for 
first experiments, which had worked well for macroscopic reactions and had given 
good results for the Baumann group (cf. Scheme 3.19). 
Synthesis using NaI in DMF at 80 °C showed a radioactive product in HPLC that was 
about 50 % of total activity. This was a surprise, since without the addition of a base 
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no formation of product was expected. It seemed possible that due to high basicity of 
the amidine the phenol was deprotonated even without addition of base. TLC 
(DCM/MeOH 9/1 + 0.1 % NEt3) showed a product, though with lower results. The 
product could not be clearly identified, since Rf-values were very close to those of 
BFE. 
Improved conditions for TLC were developed and utilized for the radio TLC 
(ethyl acetate/hexane/diethylamine 8/1/1, v/v/v). It proved that for the fluoroalkylated 
cinnamamidine a sufficient separation of precursor and standard was only possible 
by using very alkaline eluent conditions, which made it necessary to add a large 
amount of amine to the eluent. 
Using the new TLC conditions and performing radioactive synthesis again, it was 
expected to find a product with an Rf value identical to that of the authentic standard. 
Again HPLC showed 40 % to 50 % (decay corrected) of a product with retention 
times identical to those of the authentic standard compound. But TLC did not give a 
product that with a Rf value similar to that of the standard compound, showing only 
unreacted BFE (Rf 0.6 to 0.7) and a product that had a Rf of 0. It was assumed that 
this spot resulted from an ion that had formed during the reaction or due to the very 
basic eluent conditions. Different methods were used to free the ion and get a better 
Rf value. 
For monitoring reaction conditions aliquots of 20 µL were taken after 2, 4, 6, 9, 12, 
15, 20 and 30 minutes reaction time, added to an Eppendorf vial containing 30 µL of 
DCM. In order to determine if a variation of dissolving method would have an impact, 
various solvents were tested. Acetonitrile, methanol, chloroform and acetone were 
used as solvents but did not show any change in comparison to DCM. 
Another option was to add acid to the aliquot, for which tests were performed with 
trifluoro acetic acid, concentrated hydrochloric acid and glacial acetic acid. A small 
amount of acid was added to the solvent and after addition of the sample from the 
reaction briefly shaken to mix all phases and then utilized for TLC. TLC still showed 
one radioactive spot that could be identified as BFE and another that showed a Rf 
value of 0. 
As an alternative to Si-60 plates for TLC, others coated with RP-18 material 
(MeCN/H2O 35/65 + 0.1 % TFA) or aluminium oxide (AlOx, EE/Hex/DEA 8/1/1) were 
tested. With these conditions a spot remained at the starting point and only [18F]BFE 
could be identified, similar to the previous tests. To verify if the product that remained 
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at the starting point was the desired target compound, some milligrams of the 
authentic tracer were dissolved in DCM, 10 µL of that solution was added to the 
aliquot and a TLC was developed. Even though the authentic standard showed good 
retention with an Rf value of about 0.25 the radioactive product remained at the 
starting point. It could therefore be determined that this product was not the desired 
compound. 
At the same time HPLC analysis still showed a radioactive product with high yields 
that was identical to the standard compound in HPLC. Strikingly, a substantial 
non-radioactive peak could be seen in the UV spectrum of the HPLC diagram, even 
though no carrier had been added. Inquiries about possible low specific activities 
after production showed that during 2010 for the whole time frame during which 
radioactive labeling had been performed, specific activity had been worse than 
before and the [18F]fluoride produced had not been as low on carrier as before. 
This had no impact on routine production, but greatly impacted smaller scale work as 
done in the frame of the thesis. While production of [18F]BFE gave results that were 
clearly inferior to those found in the past, reactions also showed a wider range of 
product with results varying greatly between each day. To prove that the problems 
encountered with labeling were connected to the [18F]fluoride produced at the 
Baby cyclotron, [18F]fluoride was obtained from a GE PET-Trace cyclotron. Tests with 
this product showed the expected outcome with no radioactive spots but BFE on the 
plates. Therefore it can be assumed that the product that was found in previous 
measurements was a contamination of the produced [18F]fluoride from the 
Baby cyclotron. 
Correspondingly the radiochemical yields of the production of [18F]BFE rose 
significantly (cf. chapter 3.2.1). The method of production of [18F]fluoride at the 
Baby cyclotron was subsequently changed and after that change no product could be 
found anymore at the starting point on TLC plates. This proved that the radioactive 
product found so far was not the desired product but a contamination, at the same 
time neither the desired product nor any other radioactive product that would account 
for the peak found in HPLC could be found in TLC measurements. 
It was concluded that the desired product N-(2-[18F]fluoroethoxybenzyl)-
cinnamamidine [18F]3 was not produced at all. Since strikingly HPLC showed a 
product that had the same retention times as the authentic sample, it was necessary 
to conclusively prove or disprove that this product was the desired compound. 
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Figure 3.4: HPLC diagram of a radiolabeling with [18F]BFE 
(Kromasil C-18, MeCN/H2O 35/65 + 0.1%TFA, 1 mL/min, 285 nm) 
HPLC conditions until this point were a Kromasil C-18 column, with MeCN/H2O 35/65 
+ 0.1 % TFA as eluent mixture at 1 mL/min flow rate at 285 nm UV detection. For this 
system a radioactive product with a retention time of 13.57 min was found, while 
times of retention for [18F]BFE (see Figure 3.4) were 5.37 min and 9.47 min. Those 
peaks are found both with inactive BFE and freshly labeled [18F]BFE and can 
definitely be assigned to this compound. An explanation for the occurrence of two 
peaks could be an elimination reaction on the alkane removing HBr from the 
molecule leaving fluoroethene, though this cannot be proven since the authentic 
standard compound was not available. 
A co-injection of the separated radioactive product and the authentic standard was 
performed in order to verify the identity of a peak which, at approximately 13 minutes, 
was surmised to be the desired product. 
For this purpose a product fraction of 200 µL was injected directly from the reaction 
into HPLC and the desired product peak was cut after analysis. The collected fraction 
was mixed with 50 µL of a solution of the authentic standard in acetonitrile (1 mg/mL) 
and 200 µL of this solution was injected into the HPLC. After measurement 20 µL of 
the standard solution were injected and measured. It could be proven that the 
difference between retention times of the sole standard and that of the sole 
radioactive product were the same as when co-injected into HPLC (see Figure 3.5). 
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At the same time the standard compound showed retention times lower than the 
labeled compound, which is impossible, since the UV detector is situated before the 
radioactivity detector and the UV peak must have a lower retention time than the 
radioactive peak. Since the product found in HPLC could not be the desired 
compound, but retention times of the standard and the by-product were nearly the 
same, the HPLC system was deemed unsuitable for further analysis. 
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Figure 3.5: HPLC diagram of a co-injection of authentic sample and separated 
active product (Kromasil C-18, MeCN/H2O 35/65 + 0.1%TFA, 1 mL/min, 
285 nm) 
To unravel the conflicting results from HPLC and TLC an alternative HPLC system 
was established. As an alternative to a Kromasil C-18 column a Phenomenex Luna 
PFP was chosen. Eluent conditions used for analysis were identical to those for the 
Kromasil system (MeCN/H2O 35/65 + 0.1%TFA, 1 mL/min, 285 nm) and retention 
times of the radioactive compounds were comparable. Like the Kromasil system the 
Luna PFP system showed three radioactive peaks that could be assigned to BFE 
and to one unknown product. In order to identify the unknown product retention times 
for the authentic standard were determined. For measurements where the standard 
was injected into HPLC alone it gave retention times that were close to those of the 
radioactive compound. To confirm this finding, a co-injection was performed and as 
described earlier a mixture of both the authentic sample and the radioactive product 
was injected into HPLC. Both substances showed distinctly different retention times, 
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with the authentic standard having a higher retention time than the radioactive 
product. Thus it could be proven that the radioactive product found was not the 
desired compound (cf. Figure 3.6). 
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Figure 3.6: Co-injection of the separated product and the authentic standard on a 
Luna PFP column 
(Luna PFP, MeCN/H2O 35/65 + 0.1%TFA, 1 mL/min, 285 nm) 
A reaction that would account for the product found and give similar yields would be 
the formation of the N-alkylated product. In order to confirm formation of this 
compound in the labeling reaction, a synthesis of the N-fluoroethyl compound in a 
direct reaction, which should give good yields, if the reaction is favored against the 
O-alkylation, was attempted. At this point the available supply of BFE had been 
exhausted and fluoroethylmesylate was utilized instead. Due to the findings in 
radioactive analysis and the theory that the N-alkylated product was formed, it was 
expected that a reaction would occur primarily at the amine nitrogen atom under 
these reaction conditions. 
The reaction was conducted in DMF at 120 °C under addition of caesium carbonate 
and sodium iodide. It was stopped by the addition of water, once TLC showed no 
remaining reagent in the reaction solution. Analysis of the purified product was a 
surprise, since instead of the expected compound only the authentic O-alkylated 
standard compound was obtained in good yields. No N-alkylated product was found 
as proven by 2D-NMR analysis that showed the O-substituted amidine. This was 
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surprising since all trials at introducing the fluoroethoxy function were unsuccessful 
during organic synthesis of the authentic standard compounds which had led to the 
conclusion that the direct introduction was not possible. 
 
Figure 3.7: Structure of the O-alkylated (left) and the N-alkylated (right) product 
This finding suggests that the phenol is the only target of an alkylation reaction and 
hints towards this compound also being the product in a possible labeling reaction. 
Since the product actually formed in the n.c.a. radiolabeling is not the desired 
compound, it must be concluded that the product formed in the labeling reaction is 
neither the O-alkylated nor the N-alkylated compound but an unknown by-product.  
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Figure 3.8: Co-injection of the radioactive product and the authentic standard of the 
labeling reaction in DMF at 80 °C using NaOH as base 
(Luna PFP, MeCN/H2O 35/65 + 0.1%TFA, 1 mL/min, 285 nm) 
Since the synthesis of [18F]3 should generally be possible, other reaction conditions 
were explored. As originally planned the use of bases was tested in further detail. 
Adding one equivalent Cs2CO3 or five equivalents 5N NaOH did give a product that 
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showed retention times identical to the authentic standard compound and also gave 
a product on TLC that had the same Rf-values as the authentic standard (cf. Figure 
3.8). 
Co-injection showed that even though retention times of the authentic standard and 
the radiolabeled product were slightly different, adding carrier to the radiolabeled 
product showed that retention times were the same. The form of the peaks of both 
the product and the authentic standard compound in Figure 3.8, which show the 
same tailing on the UV and the radioactive scale, is striking. 
If base and sodium iodide were added to the reaction, HPLC analysis gave the same 
pattern of products as with only NaI, while TLC did not show any product. This 
strongly indicates that the peak found in HPLC does not belong to any reaction 
product but is a side product from a reaction of the NaI on the BFE or the precursor. 
Therefore the addition of NaI to the reaction was stopped and the reaction optimized 
in reference to solvent and temperature. 
As potential solvents DMF and DMSO were chosen, since they promised the best 
results. MeCN was not tested due to low solubility of the precursor and the 
restrictions of low temperatures applicable. 
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Figure 3.9: Optimization of the labeling reaction of [18F]3 (n = 1) 
The first tests with DMF gave very good results, showing 49% RCY after 30 minutes. 
Trials at reproducing these results failed and for further trials radiochemical yields 
generally were about 10 %. Raising the temperature up to 100 °C and 120 °C did not 
give much better results, staying at about 25 % to 30 % (cf. Figure 3.9). Time 
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restrictions did not allow repeating those tests and therefore these results need to be 
considered as preliminary tests that should be expanded in a later optimization work. 
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Figure 3.10: HPLC diagram of the labeling reaction of [18F]3 in DMSO at 80°C 
(Luna PFP, MeCN/H2O 35/65 + 0.1%TFA, 1 mL/min, 285 nm) 
A single test with DMSO as solvent gave excellent results, giving 78 % RCY after 30 
minutes, not showing any leftover BFE and only about 14 % of a by-product and 8 % 
unreacted fluoride (cf. Figure 3.10). These conditions therefore seem to be nearly 
perfect and encourage further investigation and optimization for preparative 
routine-labeling. 
During the course of this work it could be proven that the labeling of [18F]3 is possible 
using the methods applied and that reaction yields are very good, as long as the 
conditions are right. At the same time the bad reproducibility of the labeling reaction 
needs to be looked into further and its causes should be found and eliminated. 
3.2.4 Synthesis of 2-(2-[18F]fluoroethoxybenzyl)-isoindoline-1-imine 
After the [18F]fluoroalkyl-labeling of the cinnamamidine [18F]3 had proven successful, 
it was tried to label the cyclic precursor 19 with [18F]BFE (cf. Scheme 3.20). Reaction 
conditions were chosen similar for those of the production of [18F]3. Aliquots for TLC 
were diluted with 50 µL of dicholoromethane. Aliquots for HPLC analysis were taken 
after 15 and 30 minutes and diluted with HPLC eluent. 20 µL of this solution were 
injected into HPLC. The conditions for HPLC were similar to those used for the 
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cinnamamidine standard with exception of the eluent, which was MeCN/H2O 25/75 + 
0.1%TFA and the wavelength for UV absorption, which was set to 200 nm. 
NaOH
[18F]6
[18F]BrEtF
19
 
Scheme 3.20: Labeling reaction of the cyclic amidine [18F]6 
TLC plates, which were developed with an eluent mixture of ethyl acetate and 
propylamine in an 8/2 ratio, did not show a product and HPLC did not show any 
radioactive peak that could be identified as the desired product [18F]6 (cf. Figure 
3.11). 
It seems that reaction conditions working for the labeling of [18F]3 are not easily 
transferable to the labeling of the cyclic compound [18F]6. More tests should be 
performed to generate an optimized labeling reaction for this compound for 
performing in vitro tests to verify the potential usefulness of the tracer. 
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Figure 3.11: HPLC diagram of the labeling reaction on 19 
Luna PFP column (Luna PFP, MeCN/H2O 25/75 + 0.1%TFA, 1 mL/min, 
200 nm) 
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4 Experimental section 
4.1 General 
All experiments were conducted using chemicals obtained from one of the following 
companies: Aldrich (Germany), Fluka (Switzerland), VWR (Germany), Acros 
Organics (Belgium) or Merck (Germany). They were utilized without further cleaning 
and were of p.a. quality. 
For analytic thin layer chromatography (TLC), silica (SiO2) coated plates from 
Macherey & Nagel (Germany) were utilized. They were visualized under a UV lamp 
with the wave length of 254 nm. For column chromatographic separation, silica 
gel 60 (0.063-0.200 mm) from Merck was used. Eluent mixtures are given as volume 
proportion. Melting points were determined using a BÜCHI (B-540) melting point 
apparatus and are uncorrected. 
Mass spectra were measured on a Thermoquest Automass Multi III mass 
spectrometer. Fourier transform mass spectrometry (FTMS) spectra for determination 
of the identity of the previously unknown authentic standard compounds were 
measured at the BIOSPEC Kompetenzzentrum für organische Massenspektrometrie 
at the Forschungszentrum Jülich. 
For NMR spectra were recorded using a Bruker DPX Avance 200, chemical shifts (δ) 
are given in ppm and the internal standard was tetramethylsilane (TMS). 
For determination of radiochemical yields radio-TLC and radio-HPLC was utilized. 
Aliquots were taken from the reaction vessel and analysed using the non active 
standard as relation. Please refer to page 76 for detailed information. 
The eluent systems used for TLC to determine the Rf-values of the compounds and 
for (flash-)column chromatography are given in Table 4.1. 
Table 4.1: Eluent Systems used for TLC and column chromatography 
Eluent Proportions (v/v) Name 
Ethyl acetate/n-hexane+ 0.1% NH3 1/1 system 1 
Ethyl acetate/dipropylamine 8/2 system 2 
Ethyl acetate/n-hexane/DEA 8/1/1 system 3 
Ethyl acetate/n-hexane/DEA 4/4/2 system 4 
Ethyl acetate/n-hexane/DEA 4/5/1 system 5 
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4.2 Synthesis of standard compounds and labeling precursors 
4.2.1 2-Hydroxybenzylamine 
In a three neck flask, equipped with reflux condenser, dropping funnel and septum, 
4.935 g (41.47 mmol) of 2-hydroxybenzonitrile are dissolved in 50 mL of THF under 
argon atmosphere. Slowly 90 mL (90 mmol) of 1M borane in THF solution is added 
and after addition has finished, the mixture is refluxed for 3 hours. After cooling to 
room temperature (RT) 150 mL of 3M hydrochloric acid are added and the mixture is 
once again heated to reflux for 30 minutes and then cooled to RT. The reaction 
mixture is extracted with 2 x 150 mL of DCM, then set to alkaline with 250 mL of 2M 
NaOH and once again extracted with 2 x 150 mL DCM. 
The organic phases are combined and dried over Na2SO4 and the solvent is 
evaporated. The reaction yields 4.34 g (85 %) of crude product that is crystallized 
from methanol to give the pure product as colorless crystals. 
Yield: 3.52 g (28.6 mmol, 69 %) 
Melting point 128.3 °C 
MS (m/z) 124 
Rf-Value 
(System 3) 
0.43 
OH
NH2
1
2
3
4
5
6
7
 
           10 
1H-NMR 
(d6-DMSO) 
 δ [ppm] = 7.06 (m, 2H, H-4/6), 6.75 (m, 2H, H-3/5), 3.78 (s, 2H, H-7) 
4.2.2 General procedure for the synthesis of imidate hydrochlorides 
In a three neck flask, equipped with a gas inlet, a septum and a glass stopper, 50 to 
80 mmol of nitrile was diluted in 150 to 250 mL of absolute ethanol under argon. The 
reaction mixture was cooled to 0 °C and HCl was bubbled through for 4 hours, 
keeping the temperature between 0 °C and 5 °C. The reaction was left stirring at 
room temperature for another 18 to 72 hours, during which the product formed as 
white precipitate. The solvent was removed under vacuum and the remaining solid 
taken up with diethyl ether. After filtering off, the product was dried under vacuum 
giving the clean imidate salt. 
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4.2.2.1 Ethyl cinnamimidate hydrochloride 
Cinnamylnitril (10 mL, 80 mmol) was dissolved in 250 mL absolute ethanol and 
stirred under HCl atmosphere for 18 hours. The reaction was stopped when TLC 
showed no starting compound remaining in the reaction mixture. 
Yield: 15.25 g (72.3 mmol, 91 %) 
Melting point 128.8 °C 
MS (m/z) 176 
Rf-Value 
(System 1) 
0.62 
O
NH
1
2
3
4
5
6
7
8
9
10
11
*HCl
 
7 
1H-NMR 
(d6-DMSO) 
 δ [ppm] = 11.92 (bs, 1H, N-H), 7.92 (d, 1H, H-3), 
6.65 (m, 2H, H-5/9), 7.43 (m, 3H, H-6/7/8), 
7.22 (d, 1H, H-2), 4.58 (m, 2H, H-10), 1.39 (t, 3H, H-11) 
4.2.2.2 Ethyl 2-naphthylimidate hydrochloride 
7.659 g (50 mmol) of naphthylnitril were dissolved in 150 mL absolute ethanol and 
stirred under HCl atmosphere for 72 hours until no starting compound remained in 
the reaction mixture. 
Yield: 10.29 g (43.7 mmol, 87 %) 
Melting point n/a 
MS (m/z) 176 
Rf-Value 
(System 1) 
0.75 
O
NH
1
2
3
4
5
6
7
8
9
10
11
*HCl
12
13
 
14 
1H-NMR 
(d6-DMSO) 
 δ [ppm] = 12.06 (bs, 1H, N-H), 8.91 (s, 1H, H-11), 
8.12 (m, 4H, H-5/6/7/8), 7.75 (m, 2H, H-3/10), 
4.75 (q, 2H, H-12),1.45 (t, 3H, H-13) 
4.2.2.3 Ethyl phenylimidate hydrochloride 
Benzonitril (5.1 mL, 50 mmol) was dissolved in 150 mL absolute ethanol and stirred 
under HCl atmosphere for 72 hours. The reaction was stopped when TLC showed no 
starting compound remaining in the reaction mixture. 
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Yield: 8.85 g (47.8 mmol, 96 %) 
Melting point 120.5 °C 
MS (m/z) 150 
Rf-Value 
(System 1) 
0.77 
1
2
3
4
5
6
7
8
9O
N *HCl
 
15 
1H-NMR 
(d6-DMSO) 
 δ [ppm] = 8.20 (d, 2H, H-3/7), 7.73 (m, 3H, H-4/5/6), 
4.75 (q, 2H, H-8),1.45 (t, 3H, H-9) 
4.2.3 N-(2-Hydroxybenzyl)cinnamamidine 
In a 50 mL beaker 1.69 g (8 mmol) of imidoester 7 are dissolved in 20 mL DMF. 
1.2 mL (8 mmol) triethylamine is added and the resulting mixture briefly stirred. The 
resulting solution is filtered off into a 50 mL flask and another 1.2 mL (8 mmol) 
triethylamine and 20 mL DMF are added, and the flask is then flooded with argon. 
Finally 985.2 mg (8 mmol) of 2-hydroxybenzylamine are added. The mixture is stirred 
at room temperature for 4 hours and then evaporated to dryness. The resulting solid, 
which is crystallized from methanol, yields light yellow needles. 
Yield: 1.5 g 
(6.1 mmol, 77 %) 
Melting point 202.7 °C 
MS (m/z) 253 
Rf-Value 
(System 3) 
0.36 
OH
1
2
3
4
5
6
7N
H
NH
10
11
12
13 8
9
14
15
16
 
11 
1H-NMR 
(d6-DMSO) 
 δ [ppm] = 7.75 (m, 5H, H-12/13/14/15/16), 7.33 (s, 1H, H-10), 
7.10 (m, 2H, H-4/6), 6.75 (m, 2H, H-3/5), 
6.59 (s, 1H, H-9), 4.28 (s, 2H, H-7) 
{1H}13C-NMR 
(d6-DMSO)
 
 δ [ppm] = 162.08 (C-8), 159.26 (C-2), 136.55 (C-10), 135.91 (C-11), 
131.44 (C-13/15), 130.19 (C-6), 129.86 (C-4), 
129.47 (C-14), 128.08 (C-12/16), 126.77 (C-1), 
122.81 (C-5), 118.65 (C-3), 118.41 (C-9), 44.24 (C-7) 
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4.2.4 General procedure for the synthesis of N-(2-hydroxybenzyl)-
naphthyl amidine and N-(2-hydroxybenzyl)phenyl amidine 
In a 10 mL one neck flask 370 mg (3 mmmol) of 2-hydroxybenzyl amine 10 are 
dissolved in 10 mL absolute methanol and 0.13 g (2.4 mMol) NaOMe are added. 
After the solids have dissolved 2 mmol of the corresponding imidoester are added. 
The reaction is stirred at room temperature under argon overnight (18h) and then 
quenched with a mixture of 1 mL of concentrated hydrochloric acid in 9 mL methanol. 
After removing the solvents in vaccuo the resulting solid is crystallized from methanol 
and yields colorless crystals. 
4.2.4.1 N-(2-Hydroxybenzyl) naphthyl amidine 
Yield: 235 mg 
(0.85 mmol, 43 %) 
Melting point 170.0 °C 
MS (m/z) 277 
Rf-Value 
(System 4) 
0.42 
OH
1
2
3
4
5
6
7N
H
NH
10
11
12
13 8
9
14
15
16
17
18
 
16 
1H-NMR 
(d4-MeOH) 
 δ [ppm] = 8.11 (m, 3H, H-13/14/18), 7.78 (m, 4H, H-10/12/15/17), 
7.27 (m, 4H, H-3/4/5/6), 4.69 (d, 2H, H-7) 
4.2.4.2 N-(2-Hydroxybenzyl) phenyl amidine 
Yield: 113 mg 
(0.5 mmol, 25 %) 
MS (m/z) 227 
Rf-Value 
(System 4) 
0.50 
OH
1
2
3
4
5
6
7N
H
NH
10
11
12
13
89
14
 
17 
1H-NMR 
(d4-MeOH) 
 δ [ppm] = 7.68 (m, 5H, H-10/11/12/13/14), 7.22 (m, 4H,  H-3/4/5/6), 
4.63 (d, 2H, H-7) 
4.2.5 2-Fluoroethylmesylate 
25 g (0.39 mol) 2-fluoroethanol are dissolved in DCM and 65 mL (0.47 mol) 
triethylamine are added. The resulting mixture is cooled to 0 °C and then 33.3 mL 
(0.43 mol) methansulfonylchloride are slowly added to the solution. The cooling is 
stopped and the reaction stirred one hour at room temperature. After adding 100 mL 
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DCM the solution is extracted with 150 mL water followed by extraction with the same 
amount of 10 % hydrochloric acid, followed by extraction with 150 mL of saturated 
NaHCO3 and then 150 mL of saturated NaCl. After drying over NaSO4 the solvent is 
removed in vaccuo without heating and the resulting oil kept under argon at 7 °C. 
Yield: 48.75 g 
(0.34 mol, 88 %) 
MS (m/z) n/a 
Rf-Value n/a 
 
MsO
F
1
2  
 
33 
1H-NMR 
(CDCl3) 
 δ [ppm] = 4.82 (t, 1H, H-1), 4.55 (m, 2H, H-2), 4.42 (t, 1H, H-1), 
3.10 (s, 3H, Ms-CH3) 
4.2.6 2-Fluoroethoxysalicylaldehyde 
In a 250 mL flask 16.2 mL (0.16 mol) salicylaldehyde and 63.2 g (0.19 mol) caesium 
carbonate are dissolved in 200 mL DMF. 19.3 g (0.14 mol) of 2-fluoroethanmesylate 
are slowly added and the resulting mixture is heated to 40 °C and stirred at that 
temperature for 1 hour. After that time the heating is removed and the reaction stirred 
at room temperature for 23 hours. The mixture is then poured onto 1000 mL of ice 
water and extracted with 3 x 150 mL DCM. Drying over NaSO4 and evaporation of 
the solvent gives 28.8 g of the crude product as brown oil. For purification of the 
product column chromatography (system 1) was employed. After removal of the 
solvent the product is obtained as light yellow oil. 
Yield: 12.9 g 
(0.77 mol, 57 %) 
MS (m/z) 169 
Rf-Value n/a 
O
H1
2
3
4
5
6
7
8
F
9
O
 
               34 
1H-NMR 
(CDCl3) 
 δ [ppm] = 10.44 (s, 1H, H-7), 7.85 (d, 1H, H-2), 7.54 (t, 1H, H-4), 
7.07 (m, 2H, H-3/5), 4.95 (m, 1H, H-9), 
4.72 (m, 1H, H-9), 4.43 (m, 1H, H-8), 4.29 (m, 1H, H-8) 
19F-NMR 
(CDCl3)
 
 δ [ppm] = -223.92 
Experimental  71 
4.2.7 2-Fluoroethoxy-α-tosyl-N-boc-benzylamine 
In a 250 mL one neck flask 5 g (29.73 mmol) 2-fluoroethoxysalicylaldehyde 34 
together with 3.44g (29.73 mmol) t-butyl carbamate and 5.22 g (29.73 mmol) sodium 
p-toluenesulfinate are dissolved in a mixture of 60 mL water, 30 mL methanol and 
7.5 mL formic acid. After stirring for 15 minutes all reagents have dissolved and the 
reaction mixture is left standing without stirring for 24 hours. The product is obtained 
as colorless precipitate and is separated by filtering off the solvent. Drying over P2O5 
in an exsiccator gives the product in excellent yield. 
Yield: 9.91 g (23.4 mmol, 79 %) 
Melting point 248.0 °C 
MS (m/z) 267 (Schiff base) 
Rf-Value 
(System 5) 
0.73 
O
NHBoc1
2
3
4
5
6
7
8
F
9
Ts
 
           35 
1H-NMR 
(CDCl3) 
 δ [ppm] = 7.79 (d, 2H, Ts-H), 7.35 (m, 4H, 2 x Ts-H and H-4/6), 
7.06 (m, 1H, H-5), 6.93 (d, 1H, H-3), 6.34 (m, 1H, H-7), 
4.91 (m, 1H, H-9), 4.65 (m, 1H, H-9), 4.30 (m, 1H, H-8), 
4.17 (m, 1H, H-8), 2.44 (s, 3H, Ts-CH3), 
1.32 (s, 9H, Boc-CH3) 
19F-NMR 
(CDCl3)
 
 δ [ppm] = -224.03 
4.2.8 2-Fluoroethoxy-N-boc-benzylamine 
In a 250 mL one neck flask 3.18 g (84 mmol) sodium borohydride are dissolved in 
70 mL THF and slowly over 15 minutes 17.734 g (42 mmol) 2-fluoroethoxy-α-tosyl-N-
boc-benzylamine 35 are added. The reaction mixture is then stirred for 2 hours at 
room temperature. Subsequently it is cooled to 5 °C and 30 mL saturated ammonium 
chloride solution is added carefully to quench the reaction. After separating the 
organic phase the water phase is extracted with 3 x 30mL DMC. The organic 
fractions are combined and dried over Na2SO4 before the solvent is removed in 
vacuo. After crystallization from ethanol/water the product is obtained as colorless 
solid. 
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Yield: 10.68 g (40 mmol, 94 %) 
Melting point 145.2 °C 
MS (m/z) 270 
Rf-Value 
(System 5) 
0.83 
O
N
H1
2
3
4
5
6
7
8F
9
O
O
10 11
12
12
12
 
36 
1H-NMR 
(CDCl3) 
 δ [ppm] = 7.26 (m, 2H, H-5/6), 6.94 (m, 2H, H-3/4), 
4.90 (m, 1H, H-9), 4.66 (m, 1H, H-9), 4.35 (m, 3H, H-7/8), 
4.19 (m, 1H, H-8), 1.47 (s, 9H, H-12) 
19F-NMR 
(CDCl3)
 
 δ [ppm] = -223.92 
4.2.9 2-Fluoroethoxybenzylamine 
Into a one neck flask 10.68 g (40 mmol) of 2-fluoroethoxy-N-boc-benzylamine 36 are 
diluted in 20 mL DCM and 20 mL TFA are added. The mixture is stirred at room 
temperature for 30 minutes and then reduced to dryness. The resulting solid is 
diluted in 20 mL DCM and adjusted to pH 14 with 5M NaOH. The solution is then 
washed with each 20 mL water, NaHCO3 and saturated NaCl solution. After drying 
over Na2SO4 the crude product is obtained in quantitative yield. It is purified by 
column chromatography using system 5 producing the title compound as light yellow 
oil. 
Yield: 2.9 g (17 mmol, 43 %) 
MS (m/z) 170 
Rf-Value 
(System 5) 
0.75 
O
NH21
2
3
4
5
6
7
8F
9
 
              28 
1H-NMR 
(CDCl3) 
 δ [ppm] = 7.34 (m, 2H, H-5/6), 6.99 (m, 2H, H-3/4), 
4.93 (m, 3H, H-7/9), 4.70 (m, 1H, H-9), 4.37 (m, 1H, H-8), 
4.23 (m, 1H, H-8) 
19F-NMR 
(CDCl3)
 
 δ [ppm] = -223.72 
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4.2.10 General procedure for the synthesis of 2-fluoroethoxybenzyl 
amidines 
In a beaker 17 to 20 mmol of the imidoester are dissolved in 30 mL THF and 3.5 mL 
(20 mmol) N,N-diisopropylethylamine (Hünig’s base) are added. When a precipitate 
has formed the solution is filtered into a one neck flask. Then 3.4 g (20 mmol) 
2-fluoroethoxybenzylamine dissolved in 20 mL THF are added to the solution and it is 
stirred under argon atmosphere at room temperature for 4 hours. 
The reaction mixture is poured onto 50 mL water and then neutralized using acetic 
acid. The product is then extracted using 3 x 50 mL DCM. After drying over Na2SO4 
the solvent is evaporated in vacuo giving the crude product which is purified by 
individual means for each compound. 
4.2.10.1 N-(2-Fluoroethoxybenzyl)cinnamamidine 
The crude product is recrystallized from ethanol/water with a few drops of acetic acid 
producing colorless crystals. 
Yield: 199 mg 
(0.67 mmol, 12 %) 
Melting point 163.0 °C 
FTMS (m/z) 299.1554 
Rf-Value 
(System 3) 
0.56 
O
1
2
3
4
5
6
7
8 F
9
N
H
NH
17
16
10
11
12
13
14
15
18
 
3 
1H-NMR 
(d6-DMSO) 
 δ [ppm] = 7.78 (d, 1H, H-12), 7.66 (m, 2H, H-14/18), 
7.47 (m, 5H, H-4/6/15/16/17), 7.09 (m, 2H, H-3/5), 
6.77 (d, 1H, H-11), 4.93 (t, 1H, H-9), 4.70 (t, 1H, H-9), 
4.65 (s, 2H, H-7), 4.44 (t, 1H, H-8), 4.29 (t, 1H, H-8) 
{1H}13C-NMR 
(d6-DMSO)
 
 δ [ppm] = 160.68 (C-10), 156.66 (C-2), 143.20 (C-12), 
133.71 (C-13), 130.83 (C-15/17), 130.08 (C-6/16), 
129.92 (C-4), 128.87 (C-1), 127.97 (C-14/18), 
121.80 (C-5), 114.82 (C-3), 111.71 (C-11), 83.28 (C-9), 
67.63 (C-8), 42.00 (C-7) 
19F-NMR 
(d6-DMSO)
 
 δ [ppm] = -224.93 
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4.2.10.2 N-(2-Fluoroethoxybenzyl)naphthyl amidine 
The reaction is started using 4.1 g (17 mmol) naphthylimidoester with the amount of 
the other reagents indicated in the general description. 
The crude product is purified by column chromatography using system 2 followed by 
a second column chromatography using system 3. This produces the product as light 
beige oil. 
Yield: 1.243 g 
(3.9 mmol, 20 %) 
FTMS (m/z) 323.1554 
Rf-Value 
(System 4) 
0.74 
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1H-NMR 
(d3-MeCN) 
 δ [ppm] = 8.23 (s, 1H, H-20), 7.96 (m, 4H, H-14/15/16/17), 
7.57 (m, 3H, H-4/12/19), 7.28 (t, 1H, H-6), 
7.02 (t, 2H, H-3/5), 4.93 (t, 1H, H-9), 4.70 (t, 1H, H-9), 
4.54 (s, 2H, H-7), 4.38 (t, 1H, H-8), 4.24 (t, 1H, H-8) 
{1H}13C-NMR 
(d3-MeCN)
 
 δ [ppm] = 159.82 (C-10), 156.21 (C-2), 134.80 (C-18), 
133.96 (C-13), 132.86 (C-11), 129.06 (C-19), 
128.77 (C-1), 128.52 (C-6), 127.90 (C-4), 
127.59 (C-14/17), 129.93 (C-16), 126.55 (C-15), 
125.61 (C-12), 124.36 (C-20), 121.03 (C-5), 111.87 (C-3), 
82.55 (C-9), 67.78 (C-8), 42.63 (C-7) 
19F-NMR 
(d3-MeCN)
 
 δ [ppm] = -223.84 
4.2.10.3 N-(2-Fluoroethoxybenzyl)phenyl amidine 
The crude product is purified by column chromatography (system 2) followed by a 
second column chromatography using system 5. This produces the product as light 
beige oil. 
Yield: 227 mg (0.8 mmol, 4 %) 
FTMS (m/z) 273.1397 
Rf-Value 
(System 4) 
0.70 
O
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1H-NMR 
(d6-DMSO) 
 δ [ppm] = 7.73 (m, 2H, H-12/16), 7.45 (m, 4H, H-6/13/14/15), 
7.29 (t, 1H, H-4), 7.01 (t, 2H, H-3/5), 4.93 (t, 1H, H-9), 
4.69 (t, 1H, H-9), 4.49 (s, 2H, H-7), 4.38 (t, 1H, H-8), 
4.23 (t, 1H, H-8) 
{1H}13C-NMR 
(d6-DMSO)
 
 δ [ppm] = 160.25 (C-0, 156.20 (C-2), 137.58 (C-11), 129.78 (C-14), 
128.93 (C-6), 128.72 (C-1), 128.37 (C-13/15), 
127.88 (C-4), 126.32 (C-12/16), 121.00 (C-5), 
111.85 (C-3), 82.53 (C-9), 67.77 (C-8), 42.24 (C-7) 
19F-NMR 
(d6-DMSO)
 
 δ [ppm] = -223.96 
4.2.11 2-(2-Hydroxybenzyl)-isoindoline-1-imine 
308 mg (2.5 mmol) 2-hydroxybenzylamine are dissolved in 20 mL ethanol, 431 mg 
(2.2 mmol) 2-(bromomethyl)-benzonitrile are added and the mixture is then stirred for 
3 hours under reflux. After cooling the solvent is removed in vacuo, the resulting solid 
is washed with diethyl ether and then crystallized from methanol to produce the title 
compound as light yellow needles. 
Yield: 130 mg (0.55 mmol, 25 %) 
Melting point 51.4 °C 
MS (m/z) 239 
Rf-Value 
(System 4) 
0.61 
NH
1
2
3
45
6
8
*HCl
N OH
7
9
10
11
12
13
14
15
 
19 
1H-NMR 
(d4-MeOH) 
 δ [ppm] = 9.85 (bs, 2H, -NH/-OH), 8.29 (d, 1H, H-12), 
7.72 (m, 3H, H-10/11/13), 7.24 (m, 2H, H-4/6), 
6.90 (m, 2H, H-3/5), 4.98 (s, 2H, H-15), 4.69 (s, 2H, H-7) 
{1H}13C-NMR 
(d4-MeOH)
 
 δ [ppm] = 161.90 (C-8), 156.52 (C-2), 142.89 (C-14), 134.19 (C-12), 
130.76 (C-6), 130.72 (C-13), 129.48 (C-4), 129.26 (C-9), 
124.50 (C-10), 124.29 (C-10), 121.14 (C-1), 120.16 (C-5), 
116.28 (C-3), 56.36 (C-15), 45.53 (C-7) 
4.2.12 2-(2-Fluoroethoxybenzyl)-isoindoline-1-imine 
3.4 g (20 mmol) 2-hydroxybenzylamine are dissolved in 50 mL ethanol, 3.9 g 
(23 mmol) 2-(bromomethyl)-benzonitrile are added and the mixture is then heated to 
reflux until no starting compound remains. After 3 days the reaction is stopped by 
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letting it cool and removing the solvent in vacuo. The remaining solid is then washed 
with diethyl ether and recrystallized from ethanol/water to produce the title compound 
as colorless crystals. 
Yield: 686 mg (2.4 mmol, 12 %) 
Melting point 231.1 °C 
FTMS (m/z) 285.1397 
Rf-Value 
(System 4) 
0.49 
NH
1
2
3
45
6
8
*HCl
N O
7
9
10
11
12
13
14
15
F
16
17
 
6 
1H-NMR 
(d6-DMSO) 
 δ [ppm] = 8.34 (d, 1H, H-14), 7.68 (m, 3H, H-12/13/15), 
7.40 (m, 2H, H-4/6), 7.07 (m, 2H, H-3/5), 
5.08 (s, 2H, H-17), 4.87 (t, 1H, H-9), 4.71 (s, 2H, H-7), 
4.63 (t, 1H, H-9), 4.36 (t, 1H, H-8), 4.22 (t, 1H, H-8) 
{1H}13C-NMR 
(d6-DMSO)
 
 δ [ppm] = 161.50 (C-10), 156.73 (C-2), 142.44 (C-16), 133.75 (C-14) 
130.70 (C-6), 130.54 (C-15), 129.00 (C-4), 128.88 (C-11), 
124.05 (C-13), 123.99 (C-12), 122.65 (C-1) 121.51 (C-5), 
112.67 (C-3), 82.55 (C-9), 67.97 (C-8), 56.90 (C-17), 
45.27 (C-7), 
19F-NMR 
(d6-DMSO)
 
 δ [ppm] = -222.00 
4.3 Radiosyntheses 
4.3.1 Radioanalysis 
Radiochemical yields of desired products and by-products formed during the reaction 
are analyzed using radio-TLC. TLC plates (Polygram SIL G/UV254 40x80 mm) were 
obtained from Macherey-Nagel (Germany) and the following eluent systems were 
used. A Packard Instruments Instant ImagerTM was used for measuring the 
distribution of radioactivity on the TLC plates. 
Table 4.2: Eluent systems used for radio-TLC 
Compound Eluent Proportions (v/v) 
N-(2-[18F]Fluoroethoxybenzyl)-
cinnamamidine [18F]3 
Ethyl acetate/n-hexane+ DEA 8/1/1 
2-(2-[18F]Fluoroethoxybenzyl)-
isoindoline-1-imine [18F]6 
Ethyl acetate/dipropylamine 8/2 
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Analytic HPLC was used for determining specific activity and radiochemical yields. 
The HPLC system used consisted of a Knauer WellChrom Mini-Star K500 pump, a 
Rheodyne 7125 injection valve, a Merck/Hitachi L4000 UV/Vis photometer and a 
Na(Tl)-detector connected to a photomultiplier and amplifier (EG&G Ortec, 925 Scint 
Amplifier and Bias Supply) for determination of radioactivity. A analytical 
Kromasil 100-5 C18 (250 x 4,6 mm) column (obtained from CS-Chromatographie 
Service GmbH, Germany) was used with this system. The analysis was performed 
under isocratic conditions with a flow of 1 mL/min using one of the eluent systems 
given in Table 4.3. For analysis of the reaction progress samples of 20 µL were taken 
directly from the reaction vial and injected into the HPLC without purification. 
Table 4.3: Eluent conditions used for radio-HPLC 
Compound Eluent Proportions (v/v) 
N-(2-[18F]Fluoroethoxybenzyl)-
cinnamamidine [18F]3 
Acetonitrile/water + 0,1% TFA 35/65 
2-(2-[18F]Fluoroethoxybenzyl)-
isoindoline-1-imine [18F]6 
Acetonitrile/water + 0,1% TFA 25/75 
 
An alternative system was a analytical Phenomenex Luna PFP 100-3 (250 x 4,6 mm) 
column (obtained from Phenomenex, Germany). Here the analysis was performed 
under isocratic conditions with a flow of 1 mL/min using one of the eluent systems 
given in Table 4.3. Samples of 50 µL were taken and dissolved in the same amount 
of HPLC eluent before injection of 20µL of the prepared solution into the HPLC. For 
determination of radiochemical yields (RCY) peak activity was compared to total 
activity measured during the chromatographic analysis and is given in relation to this 
total activity. 
4.3.2 Production of n.c.a. [18F]fluoride 
Production of n.c.a. [18F]fluoride is done routinely at the institute for nuclear chemistry 
(INM-5) at the Forschungszentrum Jülich utilizing the “Baby cyclotron” BC 1710 
(JSW) or the GE PETtrace. A 18O-enriched water target is irradiated by a proton 
beam of 17 MeV generating fluorine-18 through the 18O(p,n)18F reaction. Separation 
of the product is achieved via electrostatic adsorption using a Sigradur®-Anode and 
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reelution of the product into 5-fold distilled water, after removal of the enriched target 
water. [20] 
4.3.3 Preparation of the [18F]fluoride-Kryptofix complex. 
The labeling reaction with [18F]fluoride is conducted using a dry 2.5 mL wheaton 
reactor (glass vial) made from borosilicate glass. The vial is closed with a silicone 
septum and a twist off cap, ensuring isochoric conditions, and then flushed with 
argon. For drying of the aqueous [18F]fluoride solution the reaction vial is equipped 
with connections to the argon supply and vacuum pump. 
Typically about 150 MBq [18F]fluoride solution (20 to 150 µL depending on the 
production time) are mixed with 13 µL (13 µmol) 1 M K2CO3 and 10 mg (26.56 µmol) 
Kryptofix® in 1mL acetonitrile and given into the vial. The vial is then placed into an oil 
bath set to 80°C and pressure in the vial is reduced to 800 mbar under a constant 
argon stream. After evaporation of the solvent another 1 mL actonitrile is added and 
the mixture is again reduced to dryness. Depending on the amount of water present 
before the azeotropic drying, this step is repeated up to three times. After this 
process total vacuum (~0.01 mbar) is applied to the vial for about 3-5 minutes and 
the vial again flushed with argon until atmospheric pressure is reached. 
4.3.4 Nucleophilic substitution on 1,2-dibromoethane for production of 
1-bromo-2-[18F]fluoroethane as prosthetic group 
The vial containing the dried fluoride-Kryptofix complex is heated in a second oil bath 
with a temperature of 70 °C and 2.3 µL (5 mg, 26.62 µmol) 1,2-dibromoethan 
dissolved in 1 mL acetonitrile are added to the [18F]fluoride. The reaction is left 
running for 3 minutes and then stopped by diluting the product with 19 mL of water. 
The mixture is then passed through a LiChrolut® EN cartridge which has been 
conditioned using 5 mL of methanol followed by 5 mL of water. The cartridge is dried 
by a stream of argon through it for about 1 minute. The desired product is then eluted 
from the cartridge through an AluminaB cartridge (conditioned with 5 mL DMF or 
DMSO) using 4 mL hot (70 °C) DMF or DMSO. 
The solvent is collected in four fractions of 1.4 mL, 1.0 mL and then two of 0.8 mL. 
Fraction 2 almost exclusively contains the product. Radiochemical yields of 
1-bromo-2-[18F]fluoroethane are 34 % ± 4 %. This product can be used for further 
reactions without any further purification. 
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4.3.5 Nucleophilic substitution on ethylenglycole-1,2-ditosylate for 
production of 2-[18F]fluoroethyl tosylate as prosthetic group 
After drying of the [18F]fluoride and generation of the Kryptofix complex, the vial is 
then heated in a second oil bath with a temperature of 70 °C and 4.5 mg (12 µmol) 
ethylenglycole-1,2-ditosylate dissolved in 1 mL acetonitrile are added to the 
[18F]fluoride. The reaction is stirred for 10 minutes and then stopped by diluting the 
reaction mixture with 9 mL of water. 
The mixture is then passed through a Waters tC18 cartridge which was conditioned 
using 5 mL of ethanol followed by 5 mL of water. The cartridge is purged with 5 mL of 
water and dried by purging argon through it for about 1 minute. The desired product 
is then eluted from the cartridge through an AluminaN cartridge (conditioned with 
5 mL DMF) using 4 mL hot (70 °C) DMF. 
The solvent is collected in three fractions of one time 2.0 mL and two times 1.0 mL. 
Fraction 2 almost contains most of the product. Radiochemical yields of 
[18F]fluoroethyl tosylate are 39 % ± 9 %. This product can be used for further 
reactions without any further purification. 
4.3.6 General method of synthesis of 2-[18F]fluoroethoxybenzyl amidines 
In a dry glass vial flushed with argon 25 µmol precursor, dissolved in 0.5 mL DMF or 
DMSO, is mixed with 2.4 µL 5M NaOH. 0.5 mL (~ 5 MBq) of the prosthetic group 
dissolved in the reaction solvent are added and the reaction allowed to run for 30 
minutes. During this time 50 µL aliquots are taken from the reaction after 2, 4, 6, 9, 
12, 15, 20 and 30 minutes and dissolved in 50 µL DCM or methanol. These are 
analyzed with radio-TLC and radio-HPLC. 
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5 Summary 
Radiosynthesis of a receptor ligand selective for the NMDA receptor subtype NR2B is 
of great interest for in vivo studies, since the NMDA receptor is surmised to be 
involved in the etiology of diseases like Alzheimer’s or Parkinson’s. Availability of a 
selective radioligand for that receptor subtype would enable further exploration of the 
origin of these diseases and those of others that are supposedly connected to 
malfunctions of the NMDA receptor. 
In the course of this work the synthesis of the authentic standards and labeling 
precursors for four possible radiotracers was performed. The compounds that were to 
be synthesized were chosen following a lead structure known from literature. While 
radiolabeling with a [11C]methyl group had previously been performed on the lead 
structure, in the scope of this work radiolabeling with a [18F]fluoroethyl group was 
planned. The synthesis of a 18F-analogue would be of great interest, as fluorine-18 
has a significantly longer half-life than carbon-11. Thus, while still offering 
no-carrier-added conditions, the use of fluorine-18 enables longer study times. 
The compounds to be synthesized were N-(2-[18F]fluoroethoxybenzyl)-
cinnamamidine ([18F]3), N-(2-[18F]fluoroethoxybenzyl)-naphthyl amidine ([18F]4), 
N-(2-[18F]fluoroethoxybenzyl)-phenyl amidine ([18F]5) and 2-(2-[18F]fluoroethoxy-
benzyl)-isoindoline-1-imine ([18F]6). Since the desired target compounds were not 
accessible in a direct labeling reaction, an indirect synthesis by 18F-fluoroalkylation 
using 1-bromo-2-[18F]fluoroethane was planned and executed. 
Synthesis of the necessary labeling precursors N-(2-hydroxybenzyl)-
cinnamamidine (11), N-(2-hydroxybenzyl)-naphthyl amidine (16), N-(2-hydroxy-
benzyl)-phenyl amidine (17) and the cyclic precursor 2-(2-hydroxybenzyl)-
isoindoline-1-imine (19) was performed in a two step synthesis starting from 
2-hydroxybenzylamine and the respective imidoester for the non-cyclic compounds 
and 2-hydroxybenzylamine and 2-(bromomethyl)-benzonitrile for the cyclic 
compound. 
Problems with the synthesis of 2-hydroxybenzylamine were overcome after changing 
the reaction procedure from a reduction employing hydrogen and palladium on active 
charcoal to one utilizing borane in THF. After reduction of 2-hydroxybenzonitrile with 
this reagent, the desired product 2-hydroxybenzylamine was obtained within three 
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hours of reaction time. Crystallization from methanol gave the clean product in good 
yields (69 %). 
The respective imidoesters were obtained from their nitriles in a Pinner synthesis. 
Reaction of the nitrile in absolute ethanol und hydrogen chloride atmosphere was 
successful and gave excellent yields (87 % - 96 %) after short to medium reaction 
times (18 h - 72 h). 
The cinnamyl precursor 11 was obtained after a coupling reaction between the amine 
and the imidoester in DMF using triethylamine as base. The phenyl and naphthyl 
compounds were obtained after a reaction in methanol using sodium methanolate as 
base. All precursors could be purified by crystallization from methanol and were 
suitably pure for use in a labeling reaction. Yields for the cinnamyl precursor were 
satisfying with 77 % while those for the phenyl and naphthyl compound were 
significantly lower with 25 % and 43 % respectively. 
The cyclic standard compound was synthesized directly from 2-(bromomethyl)-
benzonitrile and 2-hydroxybenzylamine by a ring closing reaction in refluxing ethanol. 
Like the other precursors crystallization from methanol gave the pure compound that 
could be employed for the labeling reaction without further purification. Like the 
phenyl and naphthyl precursor yields of the pure compound were low with 25 %. 
In order to verify identity of the labeled product in chromatographic methods the 
stable authentic fluoro-compounds were synthesized as chromatographic standards. 
Attempts of the syntheses of the authentic standards N-(2-fluoroethoxybenzyl)-
cinnamamidine (3), N-(2-fluoroethoxybenzyl)-naphthyl amidine (4), N-(2-fluoroethoxy-
benzyl)-phenyl amidine (5) and 2-(2-fluoroethoxybenzyl)-isoindoline-1-imine (6) were 
first performed on the labeling precursors, using 1-bromo-2-fluoroethane and 
different bases. Those experiments were unsuccessful and the application of 
different solvents did not enhance yields. Finally, even after the use of strong bases 
had not led to any success, reaction conditions were found that gave the desired 
product. The reaction using potassium carbonate and potassium iodide in DMF at 
120 °C gave good yields of about 70 % of the desired product. Analysis of the 
product using NMR showed that a fluorine containing by-product had been produced 
that could not be removed from the target compound by any means. It was 
concluded that alkylation of the precursor had taken place not only at the oxygen 
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atom but also at one of the nitrogen atoms of the amidine. It was therefore necessary 
to find a different method of synthesis for the desired product. 
In order to avoid potential alkylation on the nitrogen atom a reaction pathway was 
planned that started from salicylaldehyde. Introduction of the fluoroethoxy group into 
the salicylaldehyde was facile using mild reaction conditions of 40 °C in DMF and 
cesium carbonate as base. Transformation of the aldehyde into an amine was 
achieved in a three step synthesis. Introduction of the nitrogen atom into the 
molecule was achieved by reaction with tert-butylcarbamate and sodium toluene 
sulfonate. The desired product 2-fluoroethoxy-α-tosyl-N-boc-benzylamine was 
obtained in good yields of 79 % as a colorless solid and used in the next step without 
further purification. A reduction with sodium borohydride in THF was performed to 
remove the tosyl group and 2-fluoroethoxy-N-boc-benzylamine was obtained in an 
excellent yield of 94 %. 
Deprotection of the amine was achieved by stirring the tosyl compound with a 1/1 
mixture of DCM and TFA for 30 minutes at room temperature. After purification by 
flash-column chromatography the desired product 2-fluoroethoxybenzylamine was 
obtained in yields of 43 %. Coupling of the 2-fluoroethoxybenzylamine with the 
respective imidoester, or in the case of the cyclic compound 
2-(bromomethyl)-benzonitrile, gave the desired product which was then purified by 
flash-column chromatography and in the case of the cinnamyl and the cyclic 
compound by crystallization from ethanol and water. Yields for all compounds were 
low (between 4 % to 10 %) but the substances were > 99 % pure as confirmed by 
HPLC and mass spectrometry. 
Once the authentic standard compounds were available, radiolabeling could be 
conducted. For the 18F-fluoroalkylation 1-bromo-2-[18F]fluoroethane was synthesized 
starting from 1,2-dibromoethane. The desired labeled prosthetic group was obtained 
in radiochemical yields of 34 %± 4 %. An alternative route of synthesis for a 
prosthetic group was also employed using ethylenglycole-1,2-ditosylate, leading to 
radiochemical yields of 39 % ± 9 % of 2-[18F]fluoroethyl tosylate. 
The labeling reaction was performed with the cinnamyl precursor 11 using either 
DMF or DMSO as solvent at different temperatures. The n.c.a. 18F-fluoroalkylation 
with addition of sodium iodide gave a product that showed the same retention time as 
the authentic standard, but could not be verified using thin layer chromatography. 
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Co-injection of the labeled product and the authentic standard made it doubtful that 
the desired product had been obtained. Indeed changing HPLC conditions by utilizing 
a different column (Luna PFP 100-3, instead of the previously used Kromasil 100-5 
C18) showed that the product was not the desired labeled compound. 
The addition of five equivalents of sodium hydroxide to the reaction without presence 
of sodium iodide eventually showed a product different from that one so far obtained. 
Co-injection of N-(2-[18F]fluoroethoxybenzyl)-cinnamamidine (3) and the authentic 
standard compound showed the same retention time for both compounds. It was thus 
proven that the desired product was formed and subsequent experiments to optimize 
the reaction were performed. 
Both DMF and DMSO were compared as reaction solvent in preliminary tests and 
showed the formation of a product. While yields were generally lower than 30 % even 
after 30 minutes of reaction time using DMF at different temperatures (80 °C, 100 °C 
and 120 °C), DMSO gave much better yields of about 78 % at 80 °C after 30 
minutes. 
In analogy, labeling of the cyclic precursor 2-(2-hydroxybenzyl)-isoindoline-1-imine 
(19) was performed using DMSO and sodium hydroxide at 80 °C. However, no 
product could be found and the labeling reaction was unsuccessful. 
Further experiments to establish a labeling procedure for N-(2-[18F]fluoroethoxy-
benzyl)-naphthyl amidine ([18F]4), N-(2-[18F]fluoroethoxybenzyl)-phenyl amidine 
([18F]5) and 2-(2-[18F]fluoroethoxybenzyl)-isoindoline-1-imine ([18F]6) are therefore 
still necessary. However, N-(2-[18F]Fluoroethoxybenzyl)-cinnamamidine ([18F]3) has 
been successfully synthesized and is now available for in vitro and in vivo tests to 
determine its suitability as radioligand for the in vivo monitoring of the NMDA 
receptor. 
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6 List of abbreviations 
ACN acetonitrile 
BFE 1-bromo-2-fluoroethane 
Bq Becquerel 
c.a. carrier added 
c.f. carrier free 
Ci Curie (1 Ci = 3.7 · 1010 MBq) 
CNS central nervous system 
d doublet (NMR), days (half-life) 
DCM dichloromethane 
DEA diethylamine 
DMF N,N-dimethylformamide 
DMSO dimethylsulfoxide 
DPA dipropylamine 
FDG 2-fluoro-2-deoxy-D-glucose 
HPLC high performance liquid chromatography 
m multiplet (NMR) 
m.p. melting point 
n.c.a. no-carrier-added 
NMDA N-methyl-D-aspartate 
NMR nuclear magnetic resonance 
q quartet (NMR) 
PET positron emission tomography 
RCY radiochemical yield 
RT room temperature 
s singulet 
t triplett (NMR) 
TLC thin layer chromatography 
TMS tetramethylsilane
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